<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="nmo14911" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Neurogastroenterol Motil</journal-id><journal-id journal-id-type="iso-abbrev">Neurogastroenterol Motil</journal-id><journal-id journal-id-type="pmc-domain-id">379</journal-id><journal-id journal-id-type="pmc-domain">blackwellopen</journal-id><journal-id journal-id-type="publisher-id">NMO</journal-id><journal-title-group><journal-title>Neurogastroenterology and Motility</journal-title></journal-title-group><issn pub-type="ppub">1350-1925</issn><issn pub-type="epub">1365-2982</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Wiley Open Access Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11872018</article-id><article-id pub-id-type="pmcid-ver">PMC11872018.2</article-id><article-id pub-id-type="pmcaid">11872018</article-id><article-id pub-id-type="pmcaiid">11911298</article-id><article-id pub-id-type="pmid">39223918</article-id><article-id pub-id-type="doi">10.1111/nmo.14911</article-id><article-id pub-id-type="publisher-id">NMO14911</article-id><article-id pub-id-type="other">NMO-00427-2023.R1</article-id><article-version article-version-type="pmc-version">2</article-version><article-categories><subj-group subj-group-type="overline"><subject>Review</subject></subj-group><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Endocannabinoid signaling in stress, nausea, and vomiting</article-title><alt-title alt-title-type="left-running-head">DeVuono et&#160;al.</alt-title></title-group><contrib-group><contrib id="nmo14911-cr-0001" contrib-type="author" corresp="yes"><name name-style="western"><surname>DeVuono</surname><given-names initials="MV">Marieka V.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0008-9938-0993</contrib-id><xref rid="nmo14911-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>marieka.devuono@uwo.ca</email></address></contrib><contrib id="nmo14911-cr-0002" contrib-type="author"><name name-style="western"><surname>Venkatesan</surname><given-names initials="T">Thangam</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8095-7456</contrib-id><xref rid="nmo14911-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="nmo14911-cr-0003" contrib-type="author"><name name-style="western"><surname>Hillard</surname><given-names initials="CJ">Cecilia J.</given-names></name><xref rid="nmo14911-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="nmo14911-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Anatomy and Cell Biology</named-content>
<institution>Schulich School of Medicine &amp; Dentistry, Western University</institution>
<city>London</city>
<named-content content-type="country-part">Ontario</named-content>
<country country="CA">Canada</country>
</aff><aff id="nmo14911-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine</named-content>
<institution>The Ohio State University College of Medicine</institution>
<city>Columbus</city>
<named-content content-type="country-part">Ohio</named-content>
<country country="US">USA</country>
</aff><aff id="nmo14911-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Pharmacology and Toxicology and Neuroscience Research Center</named-content>
<institution>Medical College of Wisconsin</institution>
<city>Milwaukee</city>
<named-content content-type="country-part">Wisconsin</named-content>
<country country="US">USA</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Marieka V. DeVuono, Department of Anatomy and Cell Biology, Schulich School of Medicine &amp; Dentistry, Western University, London, ON, Canada, N6A 3K7.<break/>
Email: <email>marieka.devuono@uwo.ca</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>02</day><month>9</month><year>2024</year></pub-date><pub-date pub-type="ppub"><month>3</month><year>2025</year></pub-date><volume>37</volume><issue seq="120">3</issue><issue-id pub-id-type="pmc-issue-id">484307</issue-id><issue-id pub-id-type="doi">10.1111/nmo.v37.3</issue-id><elocation-id>e14911</elocation-id><history><date date-type="rev-recd"><day>06</day><month>8</month><year>2024</year></date><date date-type="received"><day>01</day><month>12</month><year>2023</year></date><date date-type="accepted"><day>20</day><month>8</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>17</day><month>03</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>18</day><month>03</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-03-18 07:25:41.480"><day>18</day><month>03</month><year>2025</year></date></event><event event-type="pmc-version" specific-use="not-live"><article-id pub-id-type="pmcaiid">11872018</article-id><article-id pub-id-type="doi">10.1111/nmo.14911</article-id><article-id pub-id-type="manuscript-id">NIHMS2019478</article-id><article-version>1</article-version><pub-date><day>02</day><month>09</month><year>2024</year></pub-date><date date-type="pmc-release"><day>01</day><month>03</month><year>2026</year></date></event><event event-type="pmc-version" specific-use="live"><article-id pub-id-type="pmcaiid">11911298</article-id><article-id pub-id-type="doi">10.1111/nmo.14911</article-id><article-version>2</article-version><pub-date><day>02</day><month>09</month><year>2024</year></pub-date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2024 The Author(s). <italic toggle="yes">Neurogastroenterology &amp; Motility</italic> published by John Wiley &amp; Sons Ltd.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="NMO-37-e14911.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:NMO-37-e14911.pdf"/><abstract><title>Abstract</title><sec id="nmo14911-sec-0001"><title>Background</title><p>Classical antiemetics that target the serotonin system may not be effective in treating certain nausea and vomiting conditions like cyclic vomiting syndrome (CVS) and cannabinoid hyperemesis syndrome (CHS). As a result, there is a need for better therapies to manage the symptoms of these disorders, including nausea, vomiting, and anxiety. Cannabis is often used for its purported antiemetic and anxiolytic effects, given regulation of these processes by the endocannabinoid system (ECS). However, there is considerable evidence that cannabinoids can also produce nausea and vomiting and increase anxiety in certain instances, especially at higher doses. This paradoxical effect of cannabinoids on nausea, vomiting, and anxiety may be due to the dysregulation of the ECS, altering how it maintains these processes and contributing to the pathophysiology of CVS or CHS.</p></sec><sec id="nmo14911-sec-0002"><title>Purpose</title><p>The purpose of this review is to highlight the involvement of the ECS in the regulation of stress, nausea, and vomiting. We discuss how prolonged cannabis use, such as in the case of CHS or heightened stress, can dysregulate the ECS and affect its modulation of these functions. The review also examines the evidence for the roles of ECS and stress systems' dysfunction in CVS and CHS to better understand the underlying mechanisms of these conditions.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="nmo14911-kwd-0001">cannabinoid 1 (CB1) receptor</kwd><kwd id="nmo14911-kwd-0002">cannabinoid hyperemesis</kwd><kwd id="nmo14911-kwd-0003">cyclic vomiting syndrome</kwd><kwd id="nmo14911-kwd-0004">endocannabinoid</kwd><kwd id="nmo14911-kwd-0005">nausea</kwd><kwd id="nmo14911-kwd-0006">stress response</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>National Institute of Diabetes and Digestive and Kidney Diseases
</institution><institution-id institution-id-type="doi">10.13039/100000062</institution-id></institution-wrap></funding-source><award-id>R13DK135315&#8208;01</award-id></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>Canadian Institutes of Health Research
</institution><institution-id institution-id-type="doi">10.13039/501100000024</institution-id></institution-wrap></funding-source><award-id>MFE&#8208;181788</award-id></award-group><award-group id="funding-0003"><funding-source><institution-wrap><institution>Canada First Research Excellence Fund
</institution><institution-id institution-id-type="doi">10.13039/501100010785</institution-id></institution-wrap></funding-source></award-group></funding-group><counts><fig-count count="1"/><table-count count="0"/><page-count count="13"/><word-count count="11200"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>March 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:16.03.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="NMO14911-cit-2001"><string-name name-style="western"><surname>DeVuono</surname><given-names>MV</given-names></string-name>, <string-name name-style="western"><surname>Venkatesan</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Hillard</surname><given-names>CJ</given-names></string-name>. <article-title>Endocannabinoid signaling in stress, nausea, and vomiting</article-title>. <source>Neurogastroenterology &amp; Motility</source>. <year>2025</year>;<volume>37</volume>:<elocation-id>e14911</elocation-id>. doi:<pub-id pub-id-type="doi">10.1111/nmo.14911</pub-id><pub-id pub-id-type="pmid">39223918</pub-id><pub-id pub-id-type="pmcid">PMC11872018</pub-id></mixed-citation>
</p></notes></front><body id="nmo14911-body-0001"><p>
<boxed-text position="anchor" content-type="box" id="nmo14911-blkfxd-0101" orientation="portrait"><caption><title>Key points</title></caption><p>
<list list-type="bullet" id="nmo14911-list-0001"><list-item id="nmo14911-li-0001"><p>The endocannabin old system (ECS)plays an important role in regulating nausea, vomiting, stress and anxiety.</p></list-item><list-item id="nmo14911-li-0002"><p>Chronic stress and/or cannabis use can alter endocannabinoidsignaling and impair its ability to modulate these functions.</p></list-item><list-item id="nmo14911-li-0003"><p>Endocannabinoid system dysfunction maycontribute to the development of Cyclic Vomiting Syndrome (CVS) or Cannabinoid Hyperemesis Syndrome (CHS).</p></list-item></list>
</p></boxed-text>
</p><sec id="nmo14911-sec-0003"><label>1</label><title>INTRODUCTION</title><p>The first&#8208;line treatments for nausea and vomiting are typically serotonin 5&#8208;HT3 receptor antagonists, which effectively prevent acute vomiting and are partially effective at preventing acute nausea associated with chemotherapy.<xref rid="nmo14911-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>, <xref rid="nmo14911-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> These classic antiemetics are sometimes ineffective at alleviating symptoms associated with certain nausea and vomiting disorders, such as cyclic vomiting syndrome (CVS) or cannabinoid hyperemesis syndrome (CHS).<xref rid="nmo14911-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="nmo14911-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="nmo14911-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> Neurokinin 1 (NK1) receptor antagonists have improved the management of nausea and vomiting; however, there is a need for better therapies that can treat both nausea and vomiting, as well as the anxiety that is associated with disorders such as CVS and CHS.<xref rid="nmo14911-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="nmo14911-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="nmo14911-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> Cannabis has historically been used as an effective antiemetic treatment for chemotherapy&#8208;induced nausea and vomiting.<xref rid="nmo14911-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> The antiemetic effects are attributed to the primary psychoactive constituent of cannabis, &#8710;<sup>9</sup>&#8208;tetrahydrocannabinol (THC),<xref rid="nmo14911-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> which has led to the development of synthetic derivatives of THC (i.e., dronabinol and nabilone) for the treatment of chemotherapy&#8208;induced nausea and vomiting.<xref rid="nmo14911-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> In addition to the anti&#8208;nausea and antiemetic effects, acutely in humans, THC generally produces subjective effects such as elevated mood, reduced anxiety, and increased sociability.<xref rid="nmo14911-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> There is growing evidence, however, that cannabinoids can also produce nausea and vomiting and increase anxiety in certain instances, particularly at higher doses.<xref rid="nmo14911-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>, <xref rid="nmo14911-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> The biphasic effects of exogenous cannabinoids on nausea, vomiting, and anxiety suggest that the endocannabinoid system's role in modulating these processes could also be biphasic.</p><p>Cannabis exerts most of its effects through modulation of the endocannabinoid system (ECS). THC is a partial agonist of the Cannabinoid 1 (CB1) receptor of the ECS.<xref rid="nmo14911-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> Synthetic derivatives can be more potent and efficacious at CB1 than THC.<xref rid="nmo14911-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> The CB1 receptor is an inhibitory G protein&#8208;coupled receptor found on presynaptic axon terminals, and when bound by endogenous ligands (i.e., endocannabinoids), such as 2&#8208;arachidonoylglycerol (2&#8208;AG) and <italic toggle="yes">N</italic>&#8208;arachidonylethanolamine (anandamide; AEA), can inhibit neurotransmitter release.<xref rid="nmo14911-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> Unlike classical neurotransmitters, endocannabinoids are not packaged in presynaptic vesicles awaiting release. Instead, endocannabinoid synthesis is triggered &#8220;on&#8208;demand&#8221; in postsynaptic neurons by neuronal activity that initiates enzymatic cascades to drive endocannabinoid synthesis from phospholipid precursors. Endocannabinoids synthesized in postsynaptic compartments travel retrogradely through poorly understood mechanisms to act on presynaptic CB1 receptors and modulate synaptic transmission. Hydrolyzing enzymes quickly terminate ECS signaling; 2&#8208;AG is catabolized by monoacylglycerol lipase (MAGL) and AEA by fatty acid amide hydrolase (FAAH).<xref rid="nmo14911-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> Thus, the activity of AEA and 2&#8208;AG as CB1 receptor agonists is greatly dependent on the activity of synthesizing and degrading enzymes. CB1 receptors are highly abundant in the central nervous system,<xref rid="nmo14911-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>, <xref rid="nmo14911-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> and endocannabinoid CB1&#8208;mediated signaling is crucial for regulating the balance of synaptic activity. ECS signaling has widespread effects, particularly related to the modulation of mood, anxiety, stress, nausea, and vomiting.<xref rid="nmo14911-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref>, <xref rid="nmo14911-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>
</p></sec><sec id="nmo14911-sec-0004"><label>2</label><title>
<styled-content style="fixed-case" toggle="no">ECS</styled-content> REGULATION OF STRESS AND ANXIETY</title><p>One of the most commonly reported reasons for cannabis use is stress relief and anxiety management.<xref rid="nmo14911-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> A cross&#8208;sectional study of 140 patients with CVS showed that of 41% who used cannabis, 80% reported feeling more relaxed because of its use and reported a reduction in nausea, vomiting, and abdominal pain, which are characteristic of a CVS attack.<xref rid="nmo14911-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> Another internet survey of 437 patients with CVS showed that, of the 81% who used cannabis, 90% stated that cannabis reduced stress levels.<xref rid="nmo14911-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref>
</p><p>There is compelling evidence that the ECS is a stress effector that acts to regulate responses to acute stressors.<xref rid="nmo14911-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> Stressors are challenges to homeostasis, the balance of biological activity which supports survival, and include events such as tissue injury, starvation, pain, psychological stress, and exercise.<xref rid="nmo14911-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref>, <xref rid="nmo14911-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> Signaling in the ECS is altered by stressors, producing changes in synaptic activity, which regulate the initiation and recovery of central stress pathways and mediate or modulate stress&#8208;associated behaviors and return to homeostasis.</p><p>Stress exposure directs activation of central stress pathways, including the hypothalamic&#8211;pituitary&#8211;adrenal (HPA) axis and the sympathetic branch of the autonomic nervous system, and promotes stress&#8208;associated behaviors, such as fear and anxiety, to cope with stressors.<xref rid="nmo14911-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref>, <xref rid="nmo14911-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref> Acute stress activates the hypothalamus and, as a result of the release of corticotropin releasing hormone (CRH), triggers pituitary release of adrenocorticotropin hormone (ACTH) to signal the adrenal glands to release glucocorticoid stress hormones.<xref rid="nmo14911-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> The release of CRH also stimulates norepinephrine (NE) release and initiates an autonomic response generated by the sympathetic nervous system (SNS), promoting arousal, attention, changes in heart rate, blood pressure, blood vessel dilation, and changes in gastrointestinal function.<xref rid="nmo14911-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> Glucocorticoids provide negative feedback to the hypothalamus and other brain regions to terminate these processes.<xref rid="nmo14911-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref>
</p><p>CRH and glucocorticoids alter endocannabinoid signaling during the initiation and termination of the stress response, respectively.<xref rid="nmo14911-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> The elevation of CRH produced by stress increases the activity of the hydrolyzing enzyme for the endocannabinoid AEA, FAAH, and augments AEA breakdown. The reduction in AEA reduces CB1 signaling, promoting excitatory glutamate release in the hypothalamus and amygdala, and activation of the stress response.<xref rid="nmo14911-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref>, <xref rid="nmo14911-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref> In the prefrontal cortex, where CB1 receptors are mainly present on inhibitory GABAergic neurons, CRH&#8208;induced AEA reductions raise GABA release, thus inhibiting the PFC negative control of stress pathways. The disinhibition further enhances hypothalamus and amygdala excitability and further contributes to the activation of the stress response.<xref rid="nmo14911-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref> These findings suggest that basal AEA concentrations constrain the stress response, and the CRH&#8208;FAAH&#8208;mediated reduction of AEA allows the stress response to become active.<xref rid="nmo14911-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> This mechanism is consistent with data demonstrating that decreased AEA concentrations are associated with susceptibility to stress, elevated circulating glucocorticoid, and anxiety&#8208;related behaviors.<xref rid="nmo14911-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref>, <xref rid="nmo14911-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref>, <xref rid="nmo14911-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref>, <xref rid="nmo14911-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref>, <xref rid="nmo14911-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref>, <xref rid="nmo14911-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref> Likewise, elevating AEA by inhibiting the enzymatic activity of FAAH is anxiolytic and reduces glucocorticoid levels in humans and laboratory animals.<xref rid="nmo14911-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref>, <xref rid="nmo14911-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref>, <xref rid="nmo14911-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref>, <xref rid="nmo14911-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref>
</p><p>In contrast to the response of AEA, 2&#8208;AG synthesis is increased following stress through a glucocorticoid&#8208;mediated mechanism.<xref rid="nmo14911-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref> After a delay following stress, glucocorticoids feedback to the hypothalamus and bind to glucocorticoid receptors to drive 2&#8208;AG synthesis and release.<xref rid="nmo14911-bib-0040" ref-type="bibr">
<sup>40</sup>
</xref> 2&#8208;AG can then bind to CB1 receptors, restoring ECS signaling to terminate the stress response and inhibit anxiety. Reduced brain 2&#8208;AG is associated with enhanced stress susceptibility, anxiety behaviors, and increased glucocorticoids.<xref rid="nmo14911-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref>, <xref rid="nmo14911-bib-0041" ref-type="bibr">
<sup>41</sup>
</xref>, <xref rid="nmo14911-bib-0042" ref-type="bibr">
<sup>42</sup>
</xref>, <xref rid="nmo14911-bib-0043" ref-type="bibr">
<sup>43</sup>
</xref> Accordingly, increased levels of 2&#8208;AG are associated with stress resiliency and blocking 2&#8208;AG breakdown by inhibiting MAGL activity can also protect against stress&#8208;induced anxiety behaviors.<xref rid="nmo14911-bib-0042" ref-type="bibr">
<sup>42</sup>
</xref>, <xref rid="nmo14911-bib-0043" ref-type="bibr">
<sup>43</sup>
</xref>, <xref rid="nmo14911-bib-0044" ref-type="bibr">
<sup>44</sup>
</xref>
</p><p>The ECS can also interact with transient receptor potential vanilloid 1 (TRPV1) channels. While primarily implicated in pain and temperature sensation, TRPV1 also participates in stress and anxiety signaling.<xref rid="nmo14911-bib-0045" ref-type="bibr">
<sup>45</sup>
</xref> Endocannabinoids, in particular AEA, are endogenous ligands of TRPV1,<xref rid="nmo14911-bib-0046" ref-type="bibr">
<sup>46</sup>
</xref> and CB1 and TRPV1 receptors are often co&#8208;expressed on neurons throughout the brain, including the amygdala.<xref rid="nmo14911-bib-0047" ref-type="bibr">
<sup>47</sup>
</xref> Similar to stress&#8208;induced FAAH activation, TRPV1 expression is increased following acute and chronic stress, likely through a glucocorticoid&#8208;CB1 mechanism.<xref rid="nmo14911-bib-0048" ref-type="bibr">
<sup>48</sup>
</xref>, <xref rid="nmo14911-bib-0049" ref-type="bibr">
<sup>49</sup>
</xref>, <xref rid="nmo14911-bib-0050" ref-type="bibr">
<sup>50</sup>
</xref> Increased TRPV1 signaling is associated with enhanced stress activation and related&#160;behaviors.<xref rid="nmo14911-bib-0051" ref-type="bibr">
<sup>51</sup>
</xref> Additionally, TPRV1 deletion leads to stress resiliency in mice,<xref rid="nmo14911-bib-0052" ref-type="bibr">
<sup>52</sup>
</xref> and antagonism of TRPV1 and dual inhibition of FAAH/TRPPV1 inhibit stress&#8208;induced anxiety&#8208;like behavior and glucocorticoid release.<xref rid="nmo14911-bib-0053" ref-type="bibr">
<sup>53</sup>
</xref>, <xref rid="nmo14911-bib-0054" ref-type="bibr">
<sup>54</sup>
</xref> Overall, these findings suggest TRPV1 channels interact with the ECS systems to properly regulate the stress response.</p><sec id="nmo14911-sec-0005"><label>2.1</label><title>
<styled-content style="fixed-case" toggle="no">ECS</styled-content> dysregulation and effects of <styled-content style="fixed-case" toggle="no">CB1</styled-content> receptor agonism</title><p>Despite relaxation being the most popular reason for cannabis use and considerable evidence that the ECS signaling is anxiolytic, a common adverse side effect of cannabis use is heightened anxiety.<xref rid="nmo14911-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> Interestingly, while ECS signaling typically inhibits stress, high doses of CB1 receptor agonists (i.e., THC or synthetic cannabinoids), but not lower doses can acutely activate stress, as indexed by increased levels of ACTH, CRH, circulating glucocorticoids and enhanced SNS activity.<xref rid="nmo14911-bib-0055" ref-type="bibr">
<sup>55</sup>
</xref>, <xref rid="nmo14911-bib-0056" ref-type="bibr">
<sup>56</sup>
</xref>, <xref rid="nmo14911-bib-0057" ref-type="bibr">
<sup>57</sup>
</xref>, <xref rid="nmo14911-bib-0058" ref-type="bibr">
<sup>58</sup>
</xref>, <xref rid="nmo14911-bib-0059" ref-type="bibr">
<sup>59</sup>
</xref> Baseline cortisol levels tend to be higher in heavy regular cannabis users than nonusers, yet cannabis users display a blunted glucocorticoid response to acute stressors suggesting HPA axis impairment.<xref rid="nmo14911-bib-0060" ref-type="bibr">
<sup>60</sup>
</xref>, <xref rid="nmo14911-bib-0061" ref-type="bibr">
<sup>61</sup>
</xref> Chronic cannabis users also tend to have increased blood pressure, heart rate and an increased skin conductance response during fear,<xref rid="nmo14911-bib-0057" ref-type="bibr">
<sup>57</sup>
</xref>, <xref rid="nmo14911-bib-0061" ref-type="bibr">
<sup>61</sup>
</xref>, <xref rid="nmo14911-bib-0062" ref-type="bibr">
<sup>62</sup>
</xref> indicative of SNS activation. In patients with CVS, Venkatesan et&#160;al.<xref rid="nmo14911-bib-0063" ref-type="bibr">
<sup>63</sup>
</xref> measured peripheral endocannabinoids, as well as salivary cortisol and alpha&#8208;amylase, markers of HPA and SNS activity, respectively, and found that cannabis users had significantly higher salivary cortisol and alpha&#8208;amylase concentrations during an acute CVS episode compared to nonusers.<xref rid="nmo14911-bib-0063" ref-type="bibr">
<sup>63</sup>
</xref> Additionally, Shah et&#160;al.<xref rid="nmo14911-bib-0064" ref-type="bibr">
<sup>64</sup>
</xref> found in a retrospective chart review that patients with CHS had higher blood pressure than patients with CVS. These findings are consistent with loss of ECS signaling and support the hypothesis that high doses of and/or prolonged exposure to CB1 agonists can enhance stress.</p><p>Consistent with other behavioral effects and the impact on stress hormones, CB1 receptor agonists exhibit dose&#8208;dependent effects on anxiety behaviors, with low doses being anxiolytic and higher doses being anxiogenic.<xref rid="nmo14911-bib-0065" ref-type="bibr">
<sup>65</sup>
</xref>, <xref rid="nmo14911-bib-0066" ref-type="bibr">
<sup>66</sup>
</xref> These studies suggest that ECS can regulate fear and anxiety circuits at multiple sites. Mouse models in which CB1 receptors have been selectively deleted from either excitatory glutamatergic or inhibitory GABAergic neurons align with this hypothesis as deletion produces opposite effects on anxiety. Specifically, CB1 deletion on glutamatergic neurons interferes with the anxiolytic effects of low doses, and deletion of CB1 on GABAergic neurons blocks anxiogenic responses to high doses of CB1 agonists.<xref rid="nmo14911-bib-0066" ref-type="bibr">
<sup>66</sup>
</xref>
</p><p>The pro&#8208;anxiety effects of CB1 receptor agonists at high doses could also be explained by ECS dysregulation. When CB1 receptor signaling is high, as occurs in the presence of high concentrations of agonists or prolonged exposure, receptors recruit &#223;&#8208;arrestin to initiate receptor desensitization, which can then lead to receptor internalization and downregulation.<xref rid="nmo14911-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="nmo14911-bib-0067" ref-type="bibr">
<sup>67</sup>
</xref>, <xref rid="nmo14911-bib-0068" ref-type="bibr">
<sup>68</sup>
</xref> Such receptor adaptations result in loss of inhibitory control provided by the CB1 receptor, dampening ECS signaling (Figure&#160;<xref rid="nmo14911-fig-0001" ref-type="fig">1</xref>). This mechanism could underlie the increase in stress and anxiety in the face of chronic high&#8208;dose THC exposure.</p><fig position="float" fig-type="FIGURE" id="nmo14911-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Representation of the influences of stress and cannabis use on Cannabinoid 1 (CB1) receptor endocannabinoid system (ECS) signaling. CB1 receptor signaling is high when endocannabinoids are available, which typically translates to reduced stress activation, suppressed anxiety, and inhibition of nausea and vomiting. When CB1 receptor signaling is low, there is often impaired stress regulation, increased anxiety, nausea, and vomiting. Healthy endocannabinoid signaling would allow for flipping between these two states and appropriate regulation of stress, nausea and vomiting; however, chronic stress exposure (orange lighting bolt) and prolonged cannabis use (green cannabis leaf) can dysregulate the ECS. Chronic stress and cannabis use alter endocannabinoid synthesis and degradation, affecting their availability. While THC itself activates the CB1 receptor, prolonged exposure can lead to desensitization and subsequent downregulation of CB1 receptors and, ultimately, reduced signaling. Chronic stress can also contribute to these receptor adaptations, thus deregulating the system to favor the low CB1 receptor signaling state and potentially contribute to the pathophysiology of cyclic vomiting syndrome (CVS) and cannabinoid hyperemesis syndrome (CHS).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="NMO-37-e14911-g001.jpg"/></fig><p>Chronic administration of high doses of CB1 agonists in rodents has also been shown to reduce CB1 receptor availability and alter levels of endocannabinoids and their synthetic and catabolic enzymes.<xref rid="nmo14911-bib-0067" ref-type="bibr">
<sup>67</sup>
</xref>, <xref rid="nmo14911-bib-0069" ref-type="bibr">
<sup>69</sup>
</xref>, <xref rid="nmo14911-bib-0070" ref-type="bibr">
<sup>70</sup>
</xref>, <xref rid="nmo14911-bib-0071" ref-type="bibr">
<sup>71</sup>
</xref>, <xref rid="nmo14911-bib-0072" ref-type="bibr">
<sup>72</sup>
</xref>, <xref rid="nmo14911-bib-0073" ref-type="bibr">
<sup>73</sup>
</xref> CB1 receptor changes are dose dependent with higher doses of CB1 agonists resulting in greater downregulation.<xref rid="nmo14911-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="nmo14911-bib-0074" ref-type="bibr">
<sup>74</sup>
</xref>, <xref rid="nmo14911-bib-0075" ref-type="bibr">
<sup>75</sup>
</xref> Moreover, ECS alterations following chronic CB1 agonism and subsequent functional recovery, are region and time&#8208;dependent as they occur at different rates and amplitudes in different brain regions.<xref rid="nmo14911-bib-0067" ref-type="bibr">
<sup>67</sup>
</xref>, <xref rid="nmo14911-bib-0068" ref-type="bibr">
<sup>68</sup>
</xref>, <xref rid="nmo14911-bib-0076" ref-type="bibr">
<sup>76</sup>
</xref> Longer CB1 receptor agonism is also associated with a more prolonged time to functional recovery.<xref rid="nmo14911-bib-0077" ref-type="bibr">
<sup>77</sup>
</xref> Correspondingly, human neuroimaging studies have demonstrated that heavy, frequent/daily cannabis use is associated with less CB1 receptor availability, which was negatively correlated with years of cannabis use, and altered endocannabinoid levels, which differed between light and heavy users.<xref rid="nmo14911-bib-0078" ref-type="bibr">
<sup>78</sup>
</xref>, <xref rid="nmo14911-bib-0079" ref-type="bibr">
<sup>79</sup>
</xref>, <xref rid="nmo14911-bib-0080" ref-type="bibr">
<sup>80</sup>
</xref>, <xref rid="nmo14911-bib-0081" ref-type="bibr">
<sup>81</sup>
</xref> The preclinical and clinical findings suggest that long&#8208;term, high&#8208;dose cannabis use as is typical in individuals with CHS, may result in profound and widespread ECS dysregulation that is resilient to recovery. Given the importance of ECS signaling in stress regulation, these changes likely contribute to the disrupted stress regulation and enhanced anxiety observed in chronic cannabis users.<xref rid="nmo14911-bib-0060" ref-type="bibr">
<sup>60</sup>
</xref>
</p><p>Chronic stress itself is associated with similar effects on ECS signaling and stress responsiveness (Figure&#160;<xref rid="nmo14911-fig-0001" ref-type="fig">1</xref>).<xref rid="nmo14911-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref>, <xref rid="nmo14911-bib-0082" ref-type="bibr">
<sup>82</sup>
</xref> Prolonged stress can lead to maladaptations of the stress response and the development of psychiatric illnesses, which are often associated with impaired glucocorticoid signaling.<xref rid="nmo14911-bib-0083" ref-type="bibr">
<sup>83</sup>
</xref> ECS dysregulation may mediate these consequences of chronic stress. Acute stress results in transient changes to the ECS to allow regulation of the stress response; however, chronic stress produces more enduring ECS adaptation, including changes to AEA and 2&#8208;AG levels and ECS enzyme activity, resulting in lowered CB1 receptor availability and reduced ECS signaling.<xref rid="nmo14911-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref>, <xref rid="nmo14911-bib-0044" ref-type="bibr">
<sup>44</sup>
</xref>, <xref rid="nmo14911-bib-0084" ref-type="bibr">
<sup>84</sup>
</xref> Prolonged glucocorticoid exposure can also elevate TRPV1 expression and potentially further impair stress regulation through interaction with the ECS.<xref rid="nmo14911-bib-0048" ref-type="bibr">
<sup>48</sup>
</xref> Given the importance of the ECS in stress homeostasis, dysregulation of its normal functioning by cannabis use or chronic stress has the potential to have profound effects that likely contribute to the adverse outcomes of chronic stress and cannabis use.</p></sec></sec><sec id="nmo14911-sec-0006"><label>3</label><title>
<styled-content style="fixed-case" toggle="no">ECS</styled-content> REGULATION OF EMESIS</title><p>One of the first recognized medicinal uses of cannabinoids was for treating chemotherapy&#8208;induced nausea and vomiting.<xref rid="nmo14911-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> Cannabis and synthetic CB1 agonists in small amounts effectively reduce acute vomiting in humans,<xref rid="nmo14911-bib-0085" ref-type="bibr">
<sup>85</sup>
</xref>, <xref rid="nmo14911-bib-0086" ref-type="bibr">
<sup>86</sup>
</xref> suggesting ECS modulation of emesis.</p><p>The brainstem's dorsal vagal complex (DVC) has been identified as a vital brain region for initiating the vomiting reflex.<xref rid="nmo14911-bib-0087" ref-type="bibr">
<sup>87</sup>
</xref> The DVC consists of the nucleus tractus solitarius (NTS), area postrema (AP), and dorsal motor nucleus (DMNX). These regions contain significant densities of serotonin 5&#8208;HT3 receptors and NK1 receptors that are necessary in emetic species for acute and delayed vomiting, respectively.<xref rid="nmo14911-bib-0088" ref-type="bibr">
<sup>88</sup>
</xref>, <xref rid="nmo14911-bib-0089" ref-type="bibr">
<sup>89</sup>
</xref> Stimuli that produce vomiting, such as chemotherapy drugs, lithium chloride (LiCl), or electrical stimulation of abdominal vagal afferents, increase serotonin (5&#8208;HT) levels in the AP and NTS which excites DMNX neurons, which produce the motor output of vomiting.<xref rid="nmo14911-bib-0089" ref-type="bibr">
<sup>89</sup>
</xref> There is also a delayed increase in NK1 activation by substance P that results in a prolonged delayed phase of vomiting.<xref rid="nmo14911-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> Thus, the DVC is the region where antiemetics such as the 5&#8208;HT3 antagonist ondansetron interfere with acute vomiting and NK1 antagonists such as aprepitant interfere with delayed vomiting.</p><p>The DVC also contains CB1 receptors. Activation of the CB1 receptors in the DVC reduces neuronal activation induced by emetic stimuli.<xref rid="nmo14911-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> Low doses of THC or synthetic CB1 receptor agonists prevent vomiting caused by chemotherapy drugs, LiCl, radiation, and motion sickness in animals capable of vomiting, such as ferrets and shrews.<xref rid="nmo14911-bib-0090" ref-type="bibr">
<sup>90</sup>
</xref>, <xref rid="nmo14911-bib-0091" ref-type="bibr">
<sup>91</sup>
</xref>, <xref rid="nmo14911-bib-0092" ref-type="bibr">
<sup>92</sup>
</xref>, <xref rid="nmo14911-bib-0093" ref-type="bibr">
<sup>93</sup>
</xref>, <xref rid="nmo14911-bib-0094" ref-type="bibr">
<sup>94</sup>
</xref> Moreover, exogenously administered endocannabinoids, 2&#8208;AG, and AEA, and enhancing ECS signaling by inhibiting 2&#8208;AG and AEA breakdown, prevent toxin&#8208;induced emesis through a CB1 receptor mechanism.<xref rid="nmo14911-bib-0047" ref-type="bibr">
<sup>47</sup>
</xref>, <xref rid="nmo14911-bib-0095" ref-type="bibr">
<sup>95</sup>
</xref>, <xref rid="nmo14911-bib-0096" ref-type="bibr">
<sup>96</sup>
</xref>, <xref rid="nmo14911-bib-0097" ref-type="bibr">
<sup>97</sup>
</xref> CB1 receptors have been identified on the terminals of 5&#8208;HT&#8208;releasing neurons.<xref rid="nmo14911-bib-0098" ref-type="bibr">
<sup>98</sup>
</xref>, <xref rid="nmo14911-bib-0099" ref-type="bibr">
<sup>99</sup>
</xref> Therefore, endocannabinoids may bind to inhibitory presynaptic CB1 receptors in the DVC to suppress 5&#8208;HT release to alleviate acute emesis.</p><p>The antiemetic effect of elevated AEA signaling may be, in part, mediated by TRPV1 channels in the NTS that co&#8208;localize with CB1 receptors. This suggests an overlap between CB1 receptors and TRPV1 channels in vomiting regulation. Enhanced AEA levels lead to activation and rapid desensitization of TRPV1 channels, resulting in an antiemetic effect.<xref rid="nmo14911-bib-0047" ref-type="bibr">
<sup>47</sup>
</xref> TRPV1 antagonism has also been shown to be antiemetic; thus, increased TRPV1 signaling likely contributes to vomiting.<xref rid="nmo14911-bib-0045" ref-type="bibr">
<sup>45</sup>
</xref>, <xref rid="nmo14911-bib-0100" ref-type="bibr">
<sup>100</sup>
</xref> TPRV1 activation also increases substance P release, a neuropeptide involved in pain processing, which could further contribute to vomiting through NK1 receptor activation.<xref rid="nmo14911-bib-0045" ref-type="bibr">
<sup>45</sup>
</xref> CB1 receptor mechanism can prevent vomiting initiated by NK1 receptor agonists or exogenous substance P,<xref rid="nmo14911-bib-0101" ref-type="bibr">
<sup>101</sup>
</xref> suggesting the ECS signaling may inhibit delayed vomiting through interaction with substance P/NK1. However, the roles of specific endocannabinoids in the relationship have yet to be established. Taken together, these findings strongly implicate the ECS in the regulation of emesis in the brain and that cannabinoid&#8208;based treatments exploit the ECS innate antiemetic mechanisms to alleviate vomiting effectively.</p></sec><sec id="nmo14911-sec-0007"><label>4</label><title>
<styled-content style="fixed-case" toggle="no">ECS</styled-content> REGULATION OF NAUSEA</title><p>In contrast to emesis, nausea is not well controlled by available antiemetics.<xref rid="nmo14911-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="nmo14911-bib-0102" ref-type="bibr">
<sup>102</sup>
</xref> Nausea is an intense adverse experience that typically accompanies vomiting but can occur independently. Indeed, distinct neuronal mechanisms underlie nausea and vomiting.<xref rid="nmo14911-bib-0103" ref-type="bibr">
<sup>103</sup>
</xref>, <xref rid="nmo14911-bib-0104" ref-type="bibr">
<sup>104</sup>
</xref> Cannabinoid&#8208;based antiemetics are more effective than 5&#8208;HT3 receptor antagonists and can enhance the anti&#8208;nausea effects of NK1 antagonists, especially to alleviate chemotherapy&#8208;induced nausea.<xref rid="nmo14911-bib-0085" ref-type="bibr">
<sup>85</sup>
</xref>, <xref rid="nmo14911-bib-0105" ref-type="bibr">
<sup>105</sup>
</xref>, <xref rid="nmo14911-bib-0106" ref-type="bibr">
<sup>106</sup>
</xref>, <xref rid="nmo14911-bib-0107" ref-type="bibr">
<sup>107</sup>
</xref> Therefore, the ECS likely plays a role in regulating nausea in addition to emesis.</p><p>The neurobiological mechanisms of nausea are less understood than vomiting, in part because nausea is challenging to measure in laboratory animals. However, rats display a conditioned gaping behavior in the taste reactivity test that offers a preclinical method to quantify nausea.<xref rid="nmo14911-bib-0108" ref-type="bibr">
<sup>108</sup>
</xref> Rats lack the motor output of vomiting; however, they do receive the same gastrointestinal and DVC signals that precede vomiting in species capable of vomiting.<xref rid="nmo14911-bib-0089" ref-type="bibr">
<sup>89</sup>
</xref> When given a novel flavor paired with an emetic agent, such as LiCl, chemotherapy drugs, or radiation, rats display a conditioned gaping response, characterized by the wide triangular opening of the mouth, when reexposed to that flavor.<xref rid="nmo14911-bib-0108" ref-type="bibr">
<sup>108</sup>
</xref>, <xref rid="nmo14911-bib-0109" ref-type="bibr">
<sup>109</sup>
</xref> The conditioned gaping behavior also engages the same orofacial muscles as vomiting in species capable of vomiting.<xref rid="nmo14911-bib-0110" ref-type="bibr">
<sup>110</sup>
</xref> Manipulations that produce nausea in species that can vomit also consistently produce conditioned gaping in rats, and treatments that alleviate nausea in emetic species also reduce conditioned gaping in rats.<xref rid="nmo14911-bib-0108" ref-type="bibr">
<sup>108</sup>
</xref> Therefore, rats provide a valuable model for studying the mechanism of nausea without the confound of vomiting, and have been used to investigate the neurobiological mechanisms responsible for nausea and the involvement of the ECS.</p><p>Although the DVC is essential for the vomiting reflex, the insular cortex has been identified as a crucial region for generating sensations of nausea and disgust.<xref rid="nmo14911-bib-0111" ref-type="bibr">
<sup>111</sup>
</xref>, <xref rid="nmo14911-bib-0112" ref-type="bibr">
<sup>112</sup>
</xref>, <xref rid="nmo14911-bib-0113" ref-type="bibr">
<sup>113</sup>
</xref> 5&#8208;HT3, NK1, and CB1 receptors are expressed in the insular cortex.<xref rid="nmo14911-bib-0114" ref-type="bibr">
<sup>114</sup>
</xref>, <xref rid="nmo14911-bib-0115" ref-type="bibr">
<sup>115</sup>
</xref> In rats, the posterior interoceptive insular cortex (IIC) receives visceral sensory input, and the anterior gustatory insular cortex (GIC) receives gustatory signals and is where the majority of output signals to autonomic brainstem structures are located.<xref rid="nmo14911-bib-0116" ref-type="bibr">
<sup>116</sup>
</xref>, <xref rid="nmo14911-bib-0117" ref-type="bibr">
<sup>117</sup>
</xref> Emetic stimuli increase neuronal activation and elevate 5&#8208;HT in the IIC while producing conditioned gaping behaviors, without affecting 5&#8208;HT in the GIC.<xref rid="nmo14911-bib-0118" ref-type="bibr">
<sup>118</sup>
</xref> Additionally, blocking 5&#8208;HT3 receptors in the IIC, but not the GIC, interferes with LiCl&#8208;induced conditioned gaping reactions suggesting IIC 5&#8208;HT3 activity is involved in establishing acute nausea.<xref rid="nmo14911-bib-0119" ref-type="bibr">
<sup>119</sup>
</xref>
</p><p>The ECS in the IIC also modulates nausea.<xref rid="nmo14911-bib-0118" ref-type="bibr">
<sup>118</sup>
</xref> At low doses, systemic and direct administration of THC and synthetic CB1 receptor agonists into the IIC prevents nausea in rats.<xref rid="nmo14911-bib-0120" ref-type="bibr">
<sup>120</sup>
</xref>, <xref rid="nmo14911-bib-0121" ref-type="bibr">
<sup>121</sup>
</xref> CB1 receptor activity in the GIC does not affect conditioned gaping,<xref rid="nmo14911-bib-0122" ref-type="bibr">
<sup>122</sup>
</xref> supporting the importance and selectivity of the CB1 receptor in the IIC. Elevating 2&#8208;AG signaling with MAGL inhibition and exogenously administered 2&#8208;AG, systemically and intra&#8208;IIC, also interfere with nausea through CB1&#8208;dependent mechanisms.<xref rid="nmo14911-bib-0097" ref-type="bibr">
<sup>97</sup>
</xref>, <xref rid="nmo14911-bib-0123" ref-type="bibr">
<sup>123</sup>
</xref>, <xref rid="nmo14911-bib-0124" ref-type="bibr">
<sup>124</sup>
</xref>, <xref rid="nmo14911-bib-0125" ref-type="bibr">
<sup>125</sup>
</xref> Interestingly, unlike vomiting, FAAH inhibition in the IIC does not reduce LiCl&#8208;induced conditioned gaping.<xref rid="nmo14911-bib-0124" ref-type="bibr">
<sup>124</sup>
</xref>, <xref rid="nmo14911-bib-0125" ref-type="bibr">
<sup>125</sup>
</xref> Systemic FAAH inhibition and peripherally restricted FAAH inhibition can interfere with LiCl nausea in rats, however, through a peroxisome proliferator&#8208;activated receptor &#945; (PPAR&#945;) mechanism, not CB1 signaling.<xref rid="nmo14911-bib-0126" ref-type="bibr">
<sup>126</sup>
</xref>, <xref rid="nmo14911-bib-0127" ref-type="bibr">
<sup>127</sup>
</xref> Therefore, the anti&#8208;nausea effects of FAAH inhibition are unlikely to be mediated by AEA but by other FAAH substrates that are PPAR&#945; agonists, including oleoylethanolamide (OEA) and palmitoylethanolamide (PEA).<xref rid="nmo14911-bib-0126" ref-type="bibr">
<sup>126</sup>
</xref>, <xref rid="nmo14911-bib-0127" ref-type="bibr">
<sup>127</sup>
</xref> Indeed, systemic and intra&#8208;IIC MAGL inhibition elevates 2&#8208;AG in the IIC, but systemic and intra&#8208;IIC FAAH inhibition does not elevate AEA in this region, but does elevate levels of OEA and PEA.<xref rid="nmo14911-bib-0124" ref-type="bibr">
<sup>124</sup>
</xref>
</p><p>The selective role of 2&#8208;AG in the IIC to reduce nausea is further supported by acute episodes of nausea elevating 2&#8208;AG, but not AEA in the IIC.<xref rid="nmo14911-bib-0124" ref-type="bibr">
<sup>124</sup>
</xref> Enhancing 2&#8208;AG signaling with MAGL inhibition also reduced neuronal activation and 5&#8208;HT release in the IIC caused by LiCl treatment.<xref rid="nmo14911-bib-0118" ref-type="bibr">
<sup>118</sup>
</xref>, <xref rid="nmo14911-bib-0124" ref-type="bibr">
<sup>124</sup>
</xref> These preclinical findings suggest that nauseating stimuli increase 5&#8208;HT release in IIC, which acts on postsynaptic 5&#8208;HT3 receptors to produce acute nausea. Activation of the 5&#8208;HT3 receptors also promotes the synthesis and release of 2&#8208;AG, which turns off the serotonergic activity via its action on presynaptic CB1 receptors in a negative feedback loop and alleviates nausea.</p><p>While the interaction between the ECS, TRPV1, substance P, and NK1 receptors have begun to be investigated in vomiting, less is known about this relationship in terms of nausea circuits specifically and remains an avenue of future research regarding the ECS signaling in nausea.</p></sec><sec id="nmo14911-sec-0008"><label>5</label><title>CANNABINOID&#8208;INDUCED NAUSEA AND VOMITING: ASSOCIATION BETWEEN <styled-content style="fixed-case" toggle="no">ECS</styled-content>, STRESS, NAUSEA, AND VOMITING</title><p>Despite the vast body of literature indicating that CB1 receptor activation prevents nausea and vomiting, there are certain instances where cannabinoids can produce nausea and vomiting. Humans commonly report nausea and vomiting as an adverse side effect associated with high doses of THC or synthetic cannabinoids.<xref rid="nmo14911-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="nmo14911-bib-0128" ref-type="bibr">
<sup>128</sup>
</xref>, <xref rid="nmo14911-bib-0129" ref-type="bibr">
<sup>129</sup>
</xref>, <xref rid="nmo14911-bib-0130" ref-type="bibr">
<sup>130</sup>
</xref>, <xref rid="nmo14911-bib-0131" ref-type="bibr">
<sup>131</sup>
</xref>, <xref rid="nmo14911-bib-0132" ref-type="bibr">
<sup>132</sup>
</xref> Perhaps, the most striking example of cannabinoid&#8208;induced nausea and vomiting is the phenomenon of CHS seen in some cannabis users.<xref rid="nmo14911-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> CHS is characterized by episodes of severe nausea, vomiting, and often abdominal pain that closely mimics the symptoms of CVS and is diagnosed using Rome IV criteria. While there have been multiple case reports and case series describing CHS, not all heavy cannabis users develop CHS; therefore, how or whether cannabis directly causes hyperemesis and if cessation leads to complete resolution of symptoms is unclear.<xref rid="nmo14911-bib-0133" ref-type="bibr">
<sup>133</sup>
</xref> A systematic review of 376 cases of CHS published in the literature demonstrated significant heterogeneity in diagnostic criteria and inadequate follow&#8208;up of cases except for the study by Allen et&#160;al. In this review, only 16% of cases met Rome IV criteria for CHS.<xref rid="nmo14911-bib-0133" ref-type="bibr">
<sup>133</sup>
</xref> Experts have postulated that CHS is a subset of CVS where chronic cannabis use exacerbates symptoms or can contribute to the development of hyperemesis in patients who are genetically predisposed to CVS or otherwise susceptible. For example, a case&#8211;control study of patients with CVS showed that polymorphisms of the gene for the CB1 receptors, CNR1, are associated with risk of CVS.<xref rid="nmo14911-bib-0134" ref-type="bibr">
<sup>134</sup>
</xref> The AG and GG genotypes of CNR1 rs806380 are associated with an increased risk of CVS, whereas the CC genotype of CNR1 rs806368 is associated with a decreased risk of CVS. Of note, the CT and CC genotypes of CNR1 rs2023239 are associated with a positive response to therapy.<xref rid="nmo14911-bib-0134" ref-type="bibr">
<sup>134</sup>
</xref> Cannabis may also interact with other yet be established variables such as genetics, age of cannabis use onset, or lifestyle factors such as nutrition and environmental stress that may aggravate symptoms further. Taken together, these data support the involvement of ECS signaling in the pathophysiology of CVS and CHS, and in nausea and vomiting regulation.</p><p>Comparable to the effect of THC on anxiety, the antiemetic and pro&#8208;emetic effects of CB1 receptor agonists are dose dependent. Low doses of CB1 receptor agonists produce antiemetic effects and offer therapeutic results for nausea and vomiting in humans and animals.<xref rid="nmo14911-bib-0085" ref-type="bibr">
<sup>85</sup>
</xref>, <xref rid="nmo14911-bib-0092" ref-type="bibr">
<sup>92</sup>
</xref>, <xref rid="nmo14911-bib-0120" ref-type="bibr">
<sup>120</sup>
</xref> However, when administered at high doses, CB1 agonists produce vomiting in several species capable of vomiting, including shrews, cats, dogs, and nonhuman primates.<xref rid="nmo14911-bib-0090" ref-type="bibr">
<sup>90</sup>
</xref>, <xref rid="nmo14911-bib-0094" ref-type="bibr">
<sup>94</sup>
</xref>, <xref rid="nmo14911-bib-0135" ref-type="bibr">
<sup>135</sup>
</xref>, <xref rid="nmo14911-bib-0136" ref-type="bibr">
<sup>136</sup>
</xref>, <xref rid="nmo14911-bib-0137" ref-type="bibr">
<sup>137</sup>
</xref> Using the taste reactivity paradigm to investigate nausea preclinically, low doses of THC and synthetic CB1 agonists prevent LiCl&#8208;induced conditioned gaping in rats.<xref rid="nmo14911-bib-0120" ref-type="bibr">
<sup>120</sup>
</xref>, <xref rid="nmo14911-bib-0122" ref-type="bibr">
<sup>122</sup>
</xref> However, when cannabinoids are themselves paired with a flavor in the taste reactivity test, high but not low doses produce conditioned gaping reactions on their own, indicating nausea.<xref rid="nmo14911-bib-0059" ref-type="bibr">
<sup>59</sup>
</xref>, <xref rid="nmo14911-bib-0073" ref-type="bibr">
<sup>73</sup>
</xref>, <xref rid="nmo14911-bib-0138" ref-type="bibr">
<sup>138</sup>
</xref> In contrast to findings with nausea produced by LiCl and cisplatin, 5&#8208;HT3 antagonism with ondansetron is not effective at preventing THC&#8208;induced nausea in rats.<xref rid="nmo14911-bib-0058" ref-type="bibr">
<sup>58</sup>
</xref> These results are consistent with the treatment of CVS and CHS in humans, where typical antiemetics are usually ineffective at alleviating symptoms, particularly nausea and anxiety.<xref rid="nmo14911-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="nmo14911-bib-0139" ref-type="bibr">
<sup>139</sup>
</xref> Nausea and vomiting associated with CVS and CHS are regularly managed with anxiolytic drugs like benzodiazepines, and the beta blocker propranolol has been shown to have some efficacy in treating symptoms of CHS.<xref rid="nmo14911-bib-0139" ref-type="bibr">
<sup>139</sup>
</xref>, <xref rid="nmo14911-bib-0140" ref-type="bibr">
<sup>140</sup>
</xref>, <xref rid="nmo14911-bib-0141" ref-type="bibr">
<sup>141</sup>
</xref> Indeed, the benzodiazepine, chlordiazepoxide, and &#223;&#8208;adrenergic receptor antagonist, propranolol, interfere with THC&#8208;induced conditioned gaping in rats.<xref rid="nmo14911-bib-0058" ref-type="bibr">
<sup>58</sup>
</xref> Other treatments that show promise in humans with CVS and CHS such as NK1 antagonists (i.e., aprepitant), tricyclic antidepressant (i.e., amitriptyline), or antipsychotic drugs (i.e., haloperidol or olanzapine), have yet to be investigated against cannabinoid&#8208;induced conditioned gaping in rats. The similarities in effective treatments between humans with CHS and cannabinoid&#8208;induced conditioned gaping in rats support using this preclinical model to investigate central mechanisms of nausea and effective treatments.</p><p>Stress and anxiety have also been hypothesized to be involved in the pathophysiology of several functional nausea and vomiting disorders including CVS and CHS.<xref rid="nmo14911-bib-0142" ref-type="bibr">
<sup>142</sup>
</xref>, <xref rid="nmo14911-bib-0143" ref-type="bibr">
<sup>143</sup>
</xref>, <xref rid="nmo14911-bib-0144" ref-type="bibr">
<sup>144</sup>
</xref>, <xref rid="nmo14911-bib-0145" ref-type="bibr">
<sup>145</sup>
</xref>, <xref rid="nmo14911-bib-0146" ref-type="bibr">
<sup>146</sup>
</xref>, <xref rid="nmo14911-bib-0147" ref-type="bibr">
<sup>147</sup>
</xref>, <xref rid="nmo14911-bib-0148" ref-type="bibr">
<sup>148</sup>
</xref>, <xref rid="nmo14911-bib-0149" ref-type="bibr">
<sup>149</sup>
</xref>, <xref rid="nmo14911-bib-0150" ref-type="bibr">
<sup>150</sup>
</xref> Given that treatments for CVS and CHS in humans and cannabinoid&#8208;induced nausea in rats are often anxiolytic, ECS dysregulation of stress and anxiety could contribute to a loss of the anti&#8208;nausea effects of ECS signaling. It remains unclear, however, if the benefits of such pharmacotherapies are due to their general sedative effect independent of their impact on stress and anxiety. It is noteworthy that non&#8208;pharmacological treatments such as psychotherapy, which target anxiety and psychological distress, can also be beneficial for CVS and CHS,<xref rid="nmo14911-bib-0151" ref-type="bibr">
<sup>151</sup>
</xref>, <xref rid="nmo14911-bib-0152" ref-type="bibr">
<sup>152</sup>
</xref>, <xref rid="nmo14911-bib-0153" ref-type="bibr">
<sup>153</sup>
</xref>, <xref rid="nmo14911-bib-0154" ref-type="bibr">
<sup>154</sup>
</xref> supporting that anxiety reduction could be part of the treatment mechanism of anxiolytic. However, this relationship requires additional investigation. Nausea, anxiety, and autonomic symptoms frequently co&#8208;occur in a prodromal phase that precedes vomiting episodes in CVS and CHS.<xref rid="nmo14911-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>, <xref rid="nmo14911-bib-0155" ref-type="bibr">
<sup>155</sup>
</xref> There is some evidence that preexisting anxiety or higher trait anxiety increases the likelihood of developing nausea and vomiting disorders irrespective of cannabis use, including anticipatory, postoperative, chronic unexplained nausea and vomiting, and even increases the chance of experiencing motion sickness or nausea following endurance exercise.<xref rid="nmo14911-bib-0142" ref-type="bibr">
<sup>142</sup>
</xref>, <xref rid="nmo14911-bib-0146" ref-type="bibr">
<sup>146</sup>
</xref>, <xref rid="nmo14911-bib-0147" ref-type="bibr">
<sup>147</sup>
</xref>, <xref rid="nmo14911-bib-0148" ref-type="bibr">
<sup>148</sup>
</xref>, <xref rid="nmo14911-bib-0149" ref-type="bibr">
<sup>149</sup>
</xref>, <xref rid="nmo14911-bib-0150" ref-type="bibr">
<sup>150</sup>
</xref> Nausea and vomiting are also associated with changes in stress reactivity and sympathetic symptoms, including sweating, flushing, thirst, hypertension, and tachycardia.<xref rid="nmo14911-bib-0063" ref-type="bibr">
<sup>63</sup>
</xref>, <xref rid="nmo14911-bib-0112" ref-type="bibr">
<sup>112</sup>
</xref>, <xref rid="nmo14911-bib-0156" ref-type="bibr">
<sup>156</sup>
</xref>, <xref rid="nmo14911-bib-0157" ref-type="bibr">
<sup>157</sup>
</xref> It has also been shown that cannabis use potentiates HPA and SNS dysfunction during vomiting, highlighting the interaction between the ECS, stress, and nausea, and vomiting.<xref rid="nmo14911-bib-0063" ref-type="bibr">
<sup>63</sup>
</xref> Therefore, the effect of excessive ECS signaling on stress could contribute to nausea and vomiting and increase the likelihood that cannabis use leads to nausea and vomiting; however, a causal relationship cannot be fully determined.</p><p>ECS dysregulation and altered stress homeostasis by extended CB1 receptor activation could, in turn, impair mechanisms controlling nausea and vomiting and potentially contribute to the pathophysiology of certain nausea and vomiting disorders like CHS or CVS in vulnerable individuals (Figure&#160;<xref rid="nmo14911-fig-0001" ref-type="fig">1</xref>).<xref rid="nmo14911-bib-0133" ref-type="bibr">
<sup>133</sup>
</xref>, <xref rid="nmo14911-bib-0143" ref-type="bibr">
<sup>143</sup>
</xref> Allostasis is the act of maintaining stability and coping with assaults to homeostasis.<xref rid="nmo14911-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> Therefore, the ECS can be considered an allostatic mechanism. When allostatic mechanisms fail or are overwhelmed by prolonged or multiple stressors, adaptations occur leading to imbalances which are associated with biological and psychiatric illnesses.<xref rid="nmo14911-bib-0158" ref-type="bibr">
<sup>158</sup>
</xref> Dysregulation of the ECS allostatic mechanisms could make it more difficult to cope with threats to homeostasis such as further cannabis use, diet changes or life stressors, and prolong the return to baseline and contribute to the cyclical nature of CVS and CHS. For example, episodes of CVS are triggered by negative stresses (loss of a loved one or examinations) in 67% and by positive events (birthdays or vacations) in 59% of patients.<xref rid="nmo14911-bib-0159" ref-type="bibr">
<sup>159</sup>
</xref> External life stressors, including the resumption of cannabis use, may also trigger CHS emetic episodes.<xref rid="nmo14911-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> Levels of peripheral endocannabinoid and related lipids have also been shown to be differentially altered between emetic and well phases in CVS patients.<xref rid="nmo14911-bib-0063" ref-type="bibr">
<sup>63</sup>
</xref>, <xref rid="nmo14911-bib-0160" ref-type="bibr">
<sup>160</sup>
</xref> Exploring the dynamics of the ECS alterations across different phases of CVS and CHS could help identify how dysfunctional ECS signaling participates in the initiation and recovery from emetic episodes.</p><p>The involvement of ECS and stress dysfunction in cannabinoid&#8208;induced nausea has been investigated further using the taste reactivity test in rats.<xref rid="nmo14911-bib-0143" ref-type="bibr">
<sup>143</sup>
</xref> Elevating ECS signaling by blocking endocannabinoid breakdown by inhibiting either MAGL or FAAH interferes with THC&#8208;induced conditioned gaping in rats.<xref rid="nmo14911-bib-0058" ref-type="bibr">
<sup>58</sup>
</xref> This is opposed to the findings with LiCl&#8208;induced nausea, where AEA signaling in the IIC does not seem to be central in acute nausea regulation.<xref rid="nmo14911-bib-0124" ref-type="bibr">
<sup>124</sup>
</xref> However, central AEA signaling is vital for stress and anxiety regulation.<xref rid="nmo14911-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> For example, as stress triggers CRH release to enhance FAAH activity and reduce AEA's inhibitory control in several stress&#8208;related brain regions, inhibition of FAAH reduced HPA axis activation by opposing the effect of CRH.<xref rid="nmo14911-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> Therefore, FAAH inhibition could elevate AEA in other brain centers to inhibit stress activation and, ultimately, produce an anti&#8208;nausea effect. In accordance with this hypothesis, CRH receptor antagonism also interferes with THC&#8208;induced nausea in rats.<xref rid="nmo14911-bib-0058" ref-type="bibr">
<sup>58</sup>
</xref> Thus, AEA augmentation is ineffective for acute nausea, where 2&#8208;AG signaling dominates, but is effective in cannabinoid&#8208;induced nausea, which is proposed to be related to stress systems where AEA is dominant in the ECS regulation.</p><sec id="nmo14911-sec-0009"><label>5.1</label><title>Potential interplay between <styled-content style="fixed-case" toggle="no">ECS</styled-content> and other neuromodulator systems in stress, nausea, and vomiting</title><p>Many patients with CHS report that topical cutaneous capsaicin cream applied to the abdomen and hot baths and/or showers produce temporary symptom relief of CHS.<xref rid="nmo14911-bib-0161" ref-type="bibr">
<sup>161</sup>
</xref> These treatments are not specific to CHS and also beneficial in CVS, and other nausea and vomiting conditions.<xref rid="nmo14911-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref>, <xref rid="nmo14911-bib-0162" ref-type="bibr">
<sup>162</sup>
</xref>, <xref rid="nmo14911-bib-0163" ref-type="bibr">
<sup>163</sup>
</xref> Capsaicin, a compound responsible for spiciness in chili peppers, high temperatures, and AEA all activate TRPV1 channels.<xref rid="nmo14911-bib-0045" ref-type="bibr">
<sup>45</sup>
</xref> TRPV1 channels are increased in response to chronic stress, partially mediated by the ECS and contribute to stress&#8208;induced visceral hyperalgesia.<xref rid="nmo14911-bib-0048" ref-type="bibr">
<sup>48</sup>
</xref>, <xref rid="nmo14911-bib-0049" ref-type="bibr">
<sup>49</sup>
</xref> ECS dysregulation caused by prolonged CB1 receptor activation or stress could indirectly alter TRPV1 signaling by affecting AEA levels. It is unknown if the relief felt by patients with CHS using these therapies is due to direct activation and rapid desensitization of TRPV1 channels correcting dysregulated channel function. An alternative explanation, consistent with the transient therapeutic effects of the TRPV1&#8208;related stimuli, is an acute episode of abdominal vasodilation that reduces visceral hyperalgesia.<xref rid="nmo14911-bib-0161" ref-type="bibr">
<sup>161</sup>
</xref>
</p><p>Activation of TRPV1 can also lead to the release of the neuropeptide substance P that binds to NK1 receptors and can contribute to pain signaling, but also nausea and vomiting.<xref rid="nmo14911-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> The availability of NK1 receptors in the amygdala has been associated with anxiety behaviors in humans.<xref rid="nmo14911-bib-0164" ref-type="bibr">
<sup>164</sup>
</xref> NK1 antagonism, like with a common antiemetic agent aprepitant, can produce antidepressant and anxiolytic effects in animal models and humans.<xref rid="nmo14911-bib-0165" ref-type="bibr">
<sup>165</sup>
</xref>, <xref rid="nmo14911-bib-0166" ref-type="bibr">
<sup>166</sup>
</xref>, <xref rid="nmo14911-bib-0167" ref-type="bibr">
<sup>167</sup>
</xref> Chronic administration of NK1 antagonists elevates AEA and 2&#8208;AG in brain regions involved in emotional regulation, and this elevation is blocked by a CB1 receptor antagonist.<xref rid="nmo14911-bib-0165" ref-type="bibr">
<sup>165</sup>
</xref> CB1 receptors facilitate NK1 receptor internalization, likely as a result of ECS&#8208;mediated increase of substance P release from TRPV1&#8208;containing neurons and highlighting the connections between these systems.<xref rid="nmo14911-bib-0168" ref-type="bibr">
<sup>168</sup>
</xref> Less is known regarding the effects of chronic stress and chronic cannabis use on NK1, which, in addition to TRPV1, warrants exploration to better understand ECS regulation of stress, nausea, and vomiting.</p><p>Antagonism of dopamine type 2 (D2) receptors with antipsychotic drugs like haloperidol produces antiemetic effects and is demonstrated to be effective at alleviating CHS symptoms in an emergency room setting.<xref rid="nmo14911-bib-0139" ref-type="bibr">
<sup>139</sup>
</xref>, <xref rid="nmo14911-bib-0169" ref-type="bibr">
<sup>169</sup>
</xref> However, the sedative effects of D2 antagonists may complicate the interpretation of these findings. D2 receptors present in the DVC have been suggested to be the site of antiemetic action of D2 antagonism.<xref rid="nmo14911-bib-0170" ref-type="bibr">
<sup>170</sup>
</xref> Further investigation is required to clarify the role of D2 receptors in nausea and the involvement of the ECS. The ECS modulates dopamine signaling indirectly through inhibition of glutamatergic and GABAergic inputs.<xref rid="nmo14911-bib-0171" ref-type="bibr">
<sup>171</sup>
</xref> It is well recognized that ECS dysregulation impacts dopaminergic signaling as well.<xref rid="nmo14911-bib-0172" ref-type="bibr">
<sup>172</sup>
</xref> Therefore, it is possible that interactions between dopamine and ECS signaling potentially contributes to symptoms associated with CHS and CVS.</p></sec></sec><sec sec-type="conclusions" id="nmo14911-sec-0010"><label>6</label><title>CONCLUSIONS</title><p>All together, these findings emphasize the relationship between the ECS, stress, nausea, and vomiting. Considerable evidence supports the associations between these systems, but further investigation is necessary to clarify the direction and causality of the correlations described in this review. Given its key modulatory role, dysregulation of the ECS can have drastic consequences for the neurobiological control of these processes. As such, the resulting ECS dysfunction produced by heightened stress, fear or anxiety, or chronic cannabis use, as is the case with CHS, may accumulate and likely play a role in the pathophysiology of nausea and vomiting disorders like CVS and CHS.</p></sec><sec id="nmo14911-sec-0012"><title>AUTHOR CONTRIBUTIONS</title><p>M.V.D., T.V., and C.J.H. all completed the literature review, prepared the manuscript, and reviewed and approved the final manuscript.</p></sec><sec sec-type="COI-statement" id="nmo14911-sec-0011"><title>CONFLICT OF INTEREST STATEMENT</title><p>C.J.H. is a member of the Scientific Advisory Committee and has equity in Formulate Biosciences.</p></sec></body><back><ack id="nmo14911-sec-0013"><title>ACKNOWLEDGMENTS</title><p>This article was supported in part by the National Institute of Health (NIH: R13DK135315&#8208;01 to T.V.), and postdoctoral fellowships to M.V.D. from the Canadian Institutes of Health Research (CIHR: MFE&#8208;181788) and the BrainsCAN Canada First Research Excellence Fund (CFREF).</p></ack><sec sec-type="data-availability" id="nmo14911-sec-0015"><title>DATA AVAILABILITY STATEMENT</title><p>Data sharing not applicable to this article as no datasets were generated or analysed during the current study.</p></sec><ref-list content-type="cited-references" id="nmo14911-bibl-0001"><title>REFERENCES</title><ref id="nmo14911-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="nmo14911-cit-0001"><string-name name-style="western"><surname>Hickok</surname><given-names>JT</given-names></string-name>, <string-name name-style="western"><surname>Roscoe</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Morrow</surname><given-names>GR</given-names></string-name>, <string-name name-style="western"><surname>King</surname><given-names>DK</given-names></string-name>, <string-name name-style="western"><surname>Atkins</surname><given-names>JN</given-names></string-name>, <string-name name-style="western"><surname>Fitch</surname><given-names>TR</given-names></string-name>. <article-title>Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5&#8208;hydroxytryptamine&#8208;3 antiemetics</article-title>. <source>Cancer</source>. <year>2003</year>;<volume>97</volume>(<issue>11</issue>):<fpage>2880</fpage>&#8208;<lpage>2886</lpage>. doi:<pub-id pub-id-type="doi">10.1002/cncr.11408</pub-id><pub-id pub-id-type="pmid">12767103</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="nmo14911-cit-0002"><string-name name-style="western"><surname>Navari</surname><given-names>RM</given-names></string-name>. <article-title>Management of chemotherapy&#8208;induced nausea and vomiting: focus on newer agents and new uses for older agents</article-title>. <source>Drugs</source>. <year>2013</year>;<volume>73</volume>(<issue>3</issue>):<fpage>249</fpage>&#8208;<lpage>262</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s40265-013-0019-1</pub-id><pub-id pub-id-type="pmid">23404093</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="nmo14911-cit-0003"><string-name name-style="western"><surname>Kamen</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Tejani</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Chandwani</surname><given-names>K</given-names></string-name>, et&#160;al. <article-title>Anticipatory nausea and vomiting due to chemotherapy</article-title>. <source>Eur J Pharmacol</source>. <year>2014</year>;<volume>722</volume>(<issue>1</issue>):<fpage>172</fpage>&#8208;<lpage>179</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ejphar.2013.09.071</pub-id><pub-id pub-id-type="pmid">24157982</pub-id><pub-id pub-id-type="pmcid">PMC3880638</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="nmo14911-cit-0004"><string-name name-style="western"><surname>Bhandari</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Venkatesan</surname><given-names>T</given-names></string-name>. <article-title>Novel treatments for cyclic vomiting syndrome: beyond ondansetron and amitriptyline</article-title>. <source>Curr Treat Options Gastroenterol</source>. <year>2016</year>;<volume>14</volume>(<issue>4</issue>):<fpage>495</fpage>&#8208;<lpage>506</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11938-016-0114-y</pub-id><pub-id pub-id-type="pmid">27757817</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="nmo14911-cit-0005"><string-name name-style="western"><surname>Richards</surname><given-names>JR</given-names></string-name>. <article-title>Cannabinoid hyperemesis syndrome: a disorder of the HPA axis and sympathetic nervous system?</article-title><source>Med Hypotheses</source>. <year>2017</year>;<volume>103</volume>:<fpage>90</fpage>&#8208;<lpage>95</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mehy.2017.04.018</pub-id><pub-id pub-id-type="pmid">28571820</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="nmo14911-cit-0006"><string-name name-style="western"><surname>Taranukha</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Charan Suresh Kumar</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Seamon</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Sahr</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Szabo</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Venkatesan</surname><given-names>T</given-names></string-name>. <article-title>Depression, young age, chronic marijuana use, and interepisodic symptoms predict psychological distress in patients with cyclic vomiting syndrome</article-title>. <source>Neurogastroenterol Motil</source>. <year>2018</year>;<volume>30</volume>(<issue>4</issue>):<elocation-id>e13245</elocation-id>. doi:<pub-id pub-id-type="doi">10.1111/nmo.13245</pub-id><pub-id pub-id-type="pmid">29152814</pub-id><pub-id pub-id-type="pmcid">PMC5878695</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="nmo14911-cit-0007"><string-name name-style="western"><surname>Andrews</surname><given-names>PLR</given-names></string-name>, <string-name name-style="western"><surname>Golding</surname><given-names>JF</given-names></string-name>, <string-name name-style="western"><surname>Sanger</surname><given-names>GJ</given-names></string-name>. <article-title>An assessment of the effects of neurokinin1 receptor antagonism against nausea and vomiting: relative efficacy, sites of action and lessons for future drug development</article-title>. <source>Br J Clin Pharmacol</source>. <year>2023</year>;<volume>89</volume>:<fpage>3468</fpage>&#8208;<lpage>3490</lpage>. doi:<pub-id pub-id-type="doi">10.1111/bcp.15852</pub-id><pub-id pub-id-type="pmid">37452618</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="nmo14911-cit-0008"><string-name name-style="western"><surname>Cristofori</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Thapar</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Saliakellis</surname><given-names>E</given-names></string-name>, et&#160;al. <article-title>Efficacy of the neurokinin&#8208;1 receptor antagonist aprepitant in children with cyclical vomiting syndrome</article-title>. <source>Aliment Pharmacol Ther</source>. <year>2014</year>;<volume>40</volume>(<issue>3</issue>):<fpage>309</fpage>&#8208;<lpage>317</lpage>. doi:<pub-id pub-id-type="doi">10.1111/apt.12822</pub-id><pub-id pub-id-type="pmid">24898244</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="nmo14911-cit-0009"><string-name name-style="western"><surname>Sharkey</surname><given-names>KA</given-names></string-name>, <string-name name-style="western"><surname>Darmani</surname><given-names>NA</given-names></string-name>, <string-name name-style="western"><surname>Parker</surname><given-names>LA</given-names></string-name>. <article-title>Regulation of nausea and vomiting by cannabinoids and the endocannabnoid system</article-title>. <source>Eur J Pharmacol</source>. <year>2014</year>;<volume>722</volume>:<fpage>134</fpage>&#8208;<lpage>146</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ejphar.2013.09.068</pub-id><pub-id pub-id-type="pmid">24184696</pub-id><pub-id pub-id-type="pmcid">PMC3883513</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="nmo14911-cit-0010"><string-name name-style="western"><surname>Van Sickle</surname><given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Oland</surname><given-names>LD</given-names></string-name>, <string-name name-style="western"><surname>Mackie</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Davison</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Sharkey</surname><given-names>KA</given-names></string-name>. <article-title>Delta9&#8208;tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source>. <year>2003</year>;<volume>285</volume>(<issue>3</issue>):<fpage>G566</fpage>&#8208;<lpage>G576</lpage>. doi:<pub-id pub-id-type="doi">10.1152/ajpgi.00113.2003</pub-id><pub-id pub-id-type="pmid">12791597</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="nmo14911-cit-0011"><string-name name-style="western"><surname>Pertwee</surname><given-names>RG</given-names></string-name>. <article-title>Emerging strategies for exploiting cannabinoid receptor agonists as medicines</article-title>. <source>Br J Pharmacol</source>. <year>2009</year>;<volume>156</volume>(<issue>3</issue>):<fpage>397</fpage>&#8208;<lpage>411</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1476-5381.2008.00048.x</pub-id><pub-id pub-id-type="pmid">19226257</pub-id><pub-id pub-id-type="pmcid">PMC2697681</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="nmo14911-cit-0012"><string-name name-style="western"><surname>Green</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Kavanagh</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Young</surname><given-names>R</given-names></string-name>. <article-title>Being stoned: a review of self&#8208;reported cannabis effects</article-title>. <source>Drug Alcohol Rev</source>. <year>2003</year>;<volume>22</volume>(<issue>4</issue>):<fpage>453</fpage>&#8208;<lpage>460</lpage>. doi:<pub-id pub-id-type="doi">10.1080/09595230310001613976</pub-id><pub-id pub-id-type="pmid">14660135</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="nmo14911-cit-0013"><string-name name-style="western"><surname>Allen</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>De Moore</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Heddle</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Twartz</surname><given-names>J</given-names></string-name>. <article-title>Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse</article-title>. <source>Gut</source>. <year>2004</year>;<volume>53</volume>(<issue>11</issue>):<fpage>1566</fpage>&#8208;<lpage>1570</lpage>. doi:<pub-id pub-id-type="doi">10.1136/gut.2003.036350</pub-id><pub-id pub-id-type="pmid">15479672</pub-id><pub-id pub-id-type="pmcid">PMC1774264</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="nmo14911-cit-0014"><string-name name-style="western"><surname>LaFrance</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Stueber</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Glodosky</surname><given-names>NC</given-names></string-name>, <string-name name-style="western"><surname>Mauzay</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Cuttler</surname><given-names>C</given-names></string-name>. <article-title>Overbaked: assessing and predicting acute adverse reactions to cannabis</article-title>. <source>J Cannabis Res</source>. <year>2020</year>;<volume>2</volume>(<issue>1</issue>):<fpage>2</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s42238-019-0013-x</pub-id><pub-id pub-id-type="pmid">33526120</pub-id><pub-id pub-id-type="pmcid">PMC7819287</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="nmo14911-cit-0015"><string-name name-style="western"><surname>Devane</surname><given-names>WA</given-names></string-name>, <string-name name-style="western"><surname>Dysarz</surname><given-names>FA</given-names></string-name>, <string-name name-style="western"><surname>Johnson</surname><given-names>MR</given-names></string-name>, <string-name name-style="western"><surname>Melvin</surname><given-names>LS</given-names></string-name>, <string-name name-style="western"><surname>Howlett</surname><given-names>AC</given-names></string-name>. <article-title>Determination and characterization of a cannabinoid receptor in rat brain</article-title>. <source>Mol Pharmacol</source>. <year>1988</year>;<volume>34</volume>(<issue>5</issue>):<fpage>605</fpage>&#8208;<lpage>613</lpage>.<pub-id pub-id-type="pmid">2848184</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="nmo14911-cit-0016"><string-name name-style="western"><surname>Breivogel</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Selley</surname><given-names>DE</given-names></string-name>, <string-name name-style="western"><surname>Childers</surname><given-names>SR</given-names></string-name>. <article-title>Cannabinoid receptor agonist efficacy for stimulating [35S]GTP gammaS binding to rat cerebellar membranes correlates with agonist&#8208;induced decreases in GDP affinity</article-title>. <source>J Biol Chem</source>. <year>1998</year>;<volume>273</volume>(<issue>27</issue>):<fpage>16865</fpage>&#8208;<lpage>16873</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.273.27.16865</pub-id><pub-id pub-id-type="pmid">9642247</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="nmo14911-cit-0017"><string-name name-style="western"><surname>Howlett</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Barth</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Bonner</surname><given-names>TI</given-names></string-name>, et&#160;al. <article-title>Classification of cannabinoid receptors</article-title>. <source>Pharmacol Rev</source>. <year>2002</year>;<volume>54</volume>(<issue>2</issue>):<fpage>161</fpage>&#8208;<lpage>202</lpage>. doi:<pub-id pub-id-type="doi">10.1124/pr.54.2.161</pub-id><pub-id pub-id-type="pmid">12037135</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="nmo14911-cit-0018"><string-name name-style="western"><surname>Bisogno</surname><given-names>T</given-names></string-name>. <article-title>Endogenous cannabinoids: structure and metabolism</article-title>. <source>J Neuroendocrinol</source>. <year>2008</year>;<volume>20</volume>(<issue>SUPPL. 1</issue>):<fpage>1</fpage>&#8208;<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2826.2008.01676.x</pub-id><pub-id pub-id-type="pmid">18426492</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="nmo14911-cit-0019"><string-name name-style="western"><surname>Herkenham</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Lynn</surname><given-names>AB</given-names></string-name>, <string-name name-style="western"><surname>Litrle</surname><given-names>MD</given-names></string-name>, et&#160;al. <article-title>Cannabinoid receptor localization in brain</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>1990</year>;<volume>87</volume>:<fpage>1932</fpage>&#8208;<lpage>1936</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.87.5.1932</pub-id><pub-id pub-id-type="pmid">2308954</pub-id><pub-id pub-id-type="pmcid">PMC53598</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="nmo14911-cit-0020"><string-name name-style="western"><surname>Biegon</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kerman</surname><given-names>IA</given-names></string-name>. <article-title>Autoradiographic study of pre&#8208; and postnatal distribution of cannabinoid receptors in human brain</article-title>. <source>Neuroimage</source>. <year>2001</year>;<volume>14</volume>(<issue>6</issue>):<fpage>1463</fpage>&#8208;<lpage>1468</lpage>. doi:<pub-id pub-id-type="doi">10.1006/nimg.2001.0939</pub-id><pub-id pub-id-type="pmid">11707102</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="nmo14911-cit-0021"><string-name name-style="western"><surname>Patel</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hillard</surname><given-names>CJ</given-names></string-name>. <article-title>Role of endocannabinoid signaling in anxiety and depression</article-title>. <source>Curr Top Behav Neurosci</source>. <year>2009</year>;<volume>1</volume>(<issue>1</issue>):<fpage>87</fpage>&#8208;<lpage>110</lpage>. doi:<pub-id pub-id-type="doi">10.1007/978-3-540-88955-7</pub-id><pub-id pub-id-type="pmid">21104391</pub-id><pub-id pub-id-type="pmcid">PMC3808114</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="nmo14911-cit-0022"><string-name name-style="western"><surname>Hyman</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Sinha</surname><given-names>R</given-names></string-name>. <article-title>Stress&#8208;related factors in cannabis use and misuse: implications for prevention and treatment</article-title>. <source>J Subst Abuse Treat</source>. <year>2009</year>;<volume>36</volume>(<issue>4</issue>):<fpage>400</fpage>&#8208;<lpage>413</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jsat.2008.08.005</pub-id><pub-id pub-id-type="pmid">19004601</pub-id><pub-id pub-id-type="pmcid">PMC2696937</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="nmo14911-cit-0023"><string-name name-style="western"><surname>Venkatesan</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Hillard</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Rein</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Banerjee</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Lisdahl</surname><given-names>K</given-names></string-name>. <article-title>Patterns of cannabis use in patients with cyclic vomiting syndrome</article-title>. <source>Clin Gastroenterol Hepatol</source>. <year>2020</year>;<volume>18</volume>(<issue>5</issue>):<fpage>1082</fpage>&#8208;<lpage>1090.e2</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cgh.2019.07.039</pub-id><pub-id pub-id-type="pmid">31352091</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="nmo14911-cit-0024"><string-name name-style="western"><surname>Venkatesan</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Sengupta</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Lodhi</surname><given-names>A</given-names></string-name>, et&#160;al. <article-title>An internet survey of marijuana and hot shower use in adults with cyclic vomiting syndrome (CVS)</article-title>. <source>Exp Brain Res</source>. <year>2014</year>;<volume>232</volume>(<issue>8</issue>):<fpage>2563</fpage>&#8208;<lpage>2570</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00221-014-3967-0</pub-id><pub-id pub-id-type="pmid">24792504</pub-id><pub-id pub-id-type="pmcid">PMC4641512</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="nmo14911-cit-0025"><string-name name-style="western"><surname>Morena</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Patel</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Bains</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Hill</surname><given-names>MN</given-names></string-name>. <article-title>Neurobiological interactions between stress and the endocannabinoid system</article-title>. <source>Neuropsychopharmacology</source>. <year>2016</year>;<volume>41</volume>(<issue>1</issue>):<fpage>80</fpage>&#8208;<lpage>102</lpage>. doi:<pub-id pub-id-type="doi">10.1038/npp.2015.166</pub-id><pub-id pub-id-type="pmid">26068727</pub-id><pub-id pub-id-type="pmcid">PMC4677118</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="nmo14911-cit-0026"><string-name name-style="western"><surname>McEwen</surname><given-names>BS</given-names></string-name>. <article-title>The neurobiology of stress: from serendipity to clinical relevance</article-title>. <source>Brain Res</source>. <year>2000</year>;<volume>886</volume>:<fpage>172</fpage>&#8208;<lpage>189</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0006-8993(00)02950-4</pub-id><pub-id pub-id-type="pmid">11119695</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="nmo14911-cit-0027"><string-name name-style="western"><surname>Hill</surname><given-names>MN</given-names></string-name>, <string-name name-style="western"><surname>Tasker</surname><given-names>JG</given-names></string-name>. <article-title>Endocannabinoid signaling, glucocorticoid&#8208;mediated negative feedback and regulation of the HPA axis</article-title>. <source>Neuroscience</source>. <year>2012</year>;<volume>204</volume>:<fpage>5</fpage>&#8208;<lpage>16</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroscience.2011.12.030</pub-id><pub-id pub-id-type="pmid">22214537</pub-id><pub-id pub-id-type="pmcid">PMC3288468</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="nmo14911-cit-0028"><string-name name-style="western"><surname>Calhoon</surname><given-names>GG</given-names></string-name>, <string-name name-style="western"><surname>Tye</surname><given-names>KM</given-names></string-name>. <article-title>Resolving the neural circuits of anxiety</article-title>. <source>Nat Neurosci</source>. <year>2015</year>;<volume>18</volume>(<issue>10</issue>):<fpage>1394</fpage>&#8208;<lpage>1404</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nn.4101</pub-id><pub-id pub-id-type="pmid">26404714</pub-id><pub-id pub-id-type="pmcid">PMC7575249</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="nmo14911-cit-0029"><string-name name-style="western"><surname>McCall</surname><given-names>JG</given-names></string-name>, <string-name name-style="western"><surname>Al&#8208;Hasani</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Siuda</surname><given-names>ER</given-names></string-name>, et&#160;al. <article-title>CRH engagement of the locus coeruleus noradrenergic system mediates stress&#8208;induced anxiety</article-title>. <source>Neuron</source>. <year>2015</year>;<volume>87</volume>(<issue>3</issue>):<fpage>605</fpage>&#8208;<lpage>620</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuron.2015.07.002</pub-id><pub-id pub-id-type="pmid">26212712</pub-id><pub-id pub-id-type="pmcid">PMC4529361</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="nmo14911-cit-0030"><string-name name-style="western"><surname>Gray</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Vecchiarelli</surname><given-names>HA</given-names></string-name>, <string-name name-style="western"><surname>Morena</surname><given-names>M</given-names></string-name>, et&#160;al. <article-title>Corticotropin&#8208;releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety</article-title>. <source>J Neurosci</source>. <year>2015</year>;<volume>35</volume>(<issue>9</issue>):<fpage>3879</fpage>&#8208;<lpage>3892</lpage>. doi:<pub-id pub-id-type="doi">10.1523/jneurosci.2737-14.2015</pub-id><pub-id pub-id-type="pmid">25740517</pub-id><pub-id pub-id-type="pmcid">PMC4348185</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="nmo14911-cit-0031"><string-name name-style="western"><surname>Petrie</surname><given-names>GN</given-names></string-name>, <string-name name-style="western"><surname>Balsevich</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>F&#252;zesi</surname><given-names>T</given-names></string-name>, et&#160;al. <article-title>Disruption of tonic endocannabinoid signaling triggers cellular, behavioral and neuroendocrine responses consistent with a stress response</article-title>. <source>Br J Pharmacol</source>. <year>2023</year>;<volume>180</volume>:<fpage>3146</fpage>&#8208;<lpage>3159</lpage>. doi:<pub-id pub-id-type="doi">10.1111/bph.16198</pub-id><pub-id pub-id-type="pmid">37482931</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="nmo14911-cit-0032"><string-name name-style="western"><surname>Gray</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Wilson</surname><given-names>CD</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>TTY</given-names></string-name>, et&#160;al. <article-title>Sustained glucocorticoid exposure recruits cortico&#8208;limbic CRH signaling to modulate endocannabinoid function</article-title>. <source>Psychoneuroendocrinology</source>. <year>2016</year>;<volume>66</volume>:<fpage>151</fpage>&#8208;<lpage>158</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.psyneuen.2016.01.004</pub-id><pub-id pub-id-type="pmid">26821211</pub-id><pub-id pub-id-type="pmcid">PMC4788523</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="nmo14911-cit-0033"><string-name name-style="western"><surname>Patel</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Roelke</surname><given-names>CT</given-names></string-name>, <string-name name-style="western"><surname>Rademacher</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Cullinan</surname><given-names>WE</given-names></string-name>, <string-name name-style="western"><surname>Hillard</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>College</surname><given-names>M</given-names></string-name>. <article-title>Endocannabinoid signaling negatively modulates stress&#8208; induced activation of the hypothalamic&#8208;pituitary&#8208; adrenal axis</article-title>. <source>Endocrinology</source>. <year>2004</year>;<volume>145</volume>(<issue>12</issue>):<fpage>5431</fpage>&#8208;<lpage>5438</lpage>. doi:<pub-id pub-id-type="doi">10.1210/en.2004-0638</pub-id><pub-id pub-id-type="pmid">15331569</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="nmo14911-cit-0034"><string-name name-style="western"><surname>Hill</surname><given-names>MN</given-names></string-name>, <string-name name-style="western"><surname>Mclaughlin</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Morrish</surname><given-names>AC</given-names></string-name>, et&#160;al. <article-title>Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic&#8208;pituitary&#8208; adrenal axis</article-title>. <source>Neuropsychopharmacology</source>. <year>2009</year>;<volume>34</volume>(<issue>13</issue>):<fpage>2733</fpage>&#8208;<lpage>2745</lpage>. doi:<pub-id pub-id-type="doi">10.1038/npp.2009.114.Suppression</pub-id><pub-id pub-id-type="pmid">19710634</pub-id><pub-id pub-id-type="pmcid">PMC3197779</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="nmo14911-cit-0035"><string-name name-style="western"><surname>Hill</surname><given-names>MN</given-names></string-name>, <string-name name-style="western"><surname>Kumar</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Filipski</surname><given-names>SB</given-names></string-name>, et&#160;al. <article-title>Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure</article-title>. <source>Mol Psychiatry</source>. <year>2013</year>;<volume>18</volume>(<issue>10</issue>):<fpage>1125</fpage>&#8208;<lpage>1135</lpage>. doi:<pub-id pub-id-type="doi">10.1038/mp.2012.90</pub-id><pub-id pub-id-type="pmid">22776900</pub-id><pub-id pub-id-type="pmcid">PMC4148304</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="nmo14911-cit-0036"><string-name name-style="western"><surname>Bluett</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Gamble&#8208;george</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Hermanson</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Hartley</surname><given-names>ND</given-names></string-name>, <string-name name-style="western"><surname>Marnett</surname><given-names>LJ</given-names></string-name>, <string-name name-style="western"><surname>Patel</surname><given-names>S</given-names></string-name>. <article-title>Central anandamide deficiency predicts stress&#8208;induced anxiety: behavioral reversal through endocannabinoid augmentation</article-title>. <source>Transl Psychiatry</source>. <year>2014</year>;<volume>4</volume>(<issue>7</issue>):<elocation-id>e408</elocation-id>. doi:<pub-id pub-id-type="doi">10.1038/tp.2014.53</pub-id><pub-id pub-id-type="pmid">25004388</pub-id><pub-id pub-id-type="pmcid">PMC4119220</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="nmo14911-cit-0037"><string-name name-style="western"><surname>Morena</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Aukema</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Leitl</surname><given-names>KD</given-names></string-name>, et&#160;al. <article-title>Upregulation of anandamide hydrolysis in the basolateral complex of amygdala reduces fear memory expression and indices of stress and anxiety</article-title>. <source>J Neurosci</source>. <year>2019</year>;<volume>39</volume>(<issue>7</issue>):<fpage>1275</fpage>&#8208;<lpage>1292</lpage>. doi:<pub-id pub-id-type="doi">10.1523/jneurosci.2251-18.2018</pub-id><pub-id pub-id-type="pmid">30573646</pub-id><pub-id pub-id-type="pmcid">PMC6381235</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="nmo14911-cit-0038"><string-name name-style="western"><surname>Mayo</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Asratian</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Lind&#233;</surname><given-names>J</given-names></string-name>, et&#160;al. <article-title>Elevated anandamide, enhanced recall of fear extinction, and attenuated stress responses following inhibition of fatty acid amide hydrolase: a randomized, controlled experimental medicine trial</article-title>. <source>Biol Psychiatry</source>. <year>2020</year>;<volume>87</volume>(<issue>6</issue>):<fpage>538</fpage>&#8208;<lpage>547</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biopsych.2019.07.034</pub-id><pub-id pub-id-type="pmid">31590924</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="nmo14911-cit-0039"><string-name name-style="western"><surname>Evanson</surname><given-names>NK</given-names></string-name>, <string-name name-style="western"><surname>Tasker</surname><given-names>JG</given-names></string-name>, <string-name name-style="western"><surname>Hill</surname><given-names>MN</given-names></string-name>, <string-name name-style="western"><surname>Hillard</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Herman</surname><given-names>JP</given-names></string-name>. <article-title>Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling</article-title>. <source>Endocrinology</source>. <year>2010</year>;<volume>151</volume>(<issue>10</issue>):<fpage>4811</fpage>&#8208;<lpage>4819</lpage>. doi:<pub-id pub-id-type="doi">10.1210/en.2010-0285</pub-id><pub-id pub-id-type="pmid">20702575</pub-id><pub-id pub-id-type="pmcid">PMC2946139</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="nmo14911-cit-0040"><string-name name-style="western"><surname>Di</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Malcher&#8208;Lopes</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Halmos</surname><given-names>KC</given-names></string-name>, <string-name name-style="western"><surname>Tasker</surname><given-names>JG</given-names></string-name>. <article-title>Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism</article-title>. <source>J Neurosci</source>. <year>2003</year>;<volume>23</volume>(<issue>12</issue>):<fpage>4850</fpage>&#8208;<lpage>4857</lpage>.<pub-id pub-id-type="pmid">12832507</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1523/JNEUROSCI.23-12-04850.2003</pub-id><pub-id pub-id-type="pmcid">PMC6741208</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="nmo14911-cit-0041"><string-name name-style="western"><surname>Shonesy</surname><given-names>BC</given-names></string-name>, <string-name name-style="western"><surname>Bluett</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Ramikie</surname><given-names>TS</given-names></string-name>, et&#160;al. <article-title>Genetic disruption of 2&#8208;arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation</article-title>. <source>Cell Rep</source>. <year>2014</year>;<volume>9</volume>(<issue>5</issue>):<fpage>1644</fpage>&#8208;<lpage>1653</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.celrep.2014.11.001</pub-id><pub-id pub-id-type="pmid">25466252</pub-id><pub-id pub-id-type="pmcid">PMC4268380</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="nmo14911-cit-0042"><string-name name-style="western"><surname>Bedse</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Hartley</surname><given-names>ND</given-names></string-name>, <string-name name-style="western"><surname>Neale</surname><given-names>E</given-names></string-name>, et&#160;al. <article-title>Functional redundancy between canonical endocannabinoid signaling systems in the modulation of anxiety</article-title>. <source>Biol Psychiatry</source>. <year>2017</year>;<volume>82</volume>:<fpage>488</fpage>&#8208;<lpage>499</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biopsych.2017.03.002</pub-id><pub-id pub-id-type="pmid">28438413</pub-id><pub-id pub-id-type="pmcid">PMC5585044</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="nmo14911-cit-0043"><string-name name-style="western"><surname>Bluett</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Baldi</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Haymer</surname><given-names>A</given-names></string-name>, et&#160;al. <article-title>Endocannabinoid signalling modulates susceptibility to traumatic stress exposure</article-title>. <source>Nature Commun</source>. <year>2017</year>;<volume>8</volume>:<elocation-id>14782</elocation-id>. doi:<pub-id pub-id-type="doi">10.1038/ncomms14782</pub-id><pub-id pub-id-type="pmid">28348378</pub-id><pub-id pub-id-type="pmcid">PMC5379055</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="nmo14911-cit-0044"><string-name name-style="western"><surname>Morena</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Leitl</surname><given-names>KD</given-names></string-name>, <string-name name-style="western"><surname>Vecchiarelli</surname><given-names>HA</given-names></string-name>, <string-name name-style="western"><surname>Gray</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Campolongo</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Hill</surname><given-names>MN</given-names></string-name>. <article-title>Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety</article-title>. <source>Neuropharmacology</source>. <year>2016</year>;<volume>111</volume>:<fpage>59</fpage>&#8208;<lpage>69</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuropharm.2016.08.020</pub-id><pub-id pub-id-type="pmid">27553121</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="nmo14911-cit-0045"><string-name name-style="western"><surname>Louis&#8208;Gray</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Tupal</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Premkumar</surname><given-names>LS</given-names></string-name>. <article-title>TRPV1: a common denominator mediating antinociceptive and antiemetic effects of cannabinoids</article-title>. <source>Int J Mol Sci</source>. <year>2022</year>;<volume>23</volume>(<issue>17</issue>):<fpage>10016</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms231710016</pub-id><pub-id pub-id-type="pmid">36077412</pub-id><pub-id pub-id-type="pmcid">PMC9456209</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="nmo14911-cit-0046"><string-name name-style="western"><surname>Muller</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Morales</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Reggio</surname><given-names>PH</given-names></string-name>. <article-title>Cannabinoid ligands targeting TRP channels</article-title>. <source>Front Mol Neurosci</source>. <year>2019</year>;<volume>11</volume>:<elocation-id>487</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fnmol.2018.00487</pub-id><pub-id pub-id-type="pmid">30697147</pub-id><pub-id pub-id-type="pmcid">PMC6340993</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="nmo14911-cit-0047"><string-name name-style="western"><surname>Sharkey</surname><given-names>KA</given-names></string-name>, <string-name name-style="western"><surname>Cristino</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Oland</surname><given-names>LD</given-names></string-name>, et&#160;al. <article-title>Arvanil, anandamide and N &#8208;arachidonoyl&#8208;dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret</article-title>. <source>Eur J Neurosci</source>. <year>2007</year>;<volume>25</volume>:<fpage>2773</fpage>&#8208;<lpage>2782</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1460-9568.2007.05521.x</pub-id><pub-id pub-id-type="pmid">17459108</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="nmo14911-cit-0048"><string-name name-style="western"><surname>Hong</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Zheng</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Snider</surname><given-names>NT</given-names></string-name>, <string-name name-style="western"><surname>Owyang</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Wiley</surname><given-names>JW</given-names></string-name>. <article-title>Corticosterone mediates reciprocal changes in CB 1 and TRPV1 receptors in primary sensory neurons in the chronically stressed rat</article-title>. <source>Gastroenterology</source>. <year>2011</year>;<volume>140</volume>(<issue>2</issue>):<fpage>627</fpage>&#8208;<lpage>637.e4</lpage>. doi:<pub-id pub-id-type="doi">10.1053/j.gastro.2010.11.003</pub-id><pub-id pub-id-type="pmid">21070780</pub-id><pub-id pub-id-type="pmcid">PMC3031761</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="nmo14911-cit-0049"><string-name name-style="western"><surname>Hong</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Fan</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kemmerer</surname><given-names>ES</given-names></string-name>, <string-name name-style="western"><surname>Evans</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wiley</surname><given-names>JW</given-names></string-name>. <article-title>Reciprocal changes in vanilloid (TRPV1) and endocannabinoid (CB1) receptors contribute to visceral hyperalgesia in the water avoidance stressed rat</article-title>. <source>Gut</source>. <year>2009</year>;<volume>58</volume>(<issue>2</issue>):<fpage>202</fpage>&#8208;<lpage>210</lpage>. doi:<pub-id pub-id-type="doi">10.1136/gut.2008.157594</pub-id><pub-id pub-id-type="pmid">18936104</pub-id><pub-id pub-id-type="pmcid">PMC4236191</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="nmo14911-cit-0050"><string-name name-style="western"><surname>Soca&#322;a</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Wla&#378;</surname><given-names>P</given-names></string-name>. <article-title>Evaluation of the antidepressant&#8208; and anxiolytic&#8208;like activity of &#945;&#8208;spinasterol, a plant derivative with TRPV1 antagonistic effects, in mice</article-title>. <source>Behav Brain Res</source>. <year>2016</year>;<volume>303</volume>:<fpage>19</fpage>&#8208;<lpage>25</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbr.2016.01.048</pub-id><pub-id pub-id-type="pmid">26808607</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="nmo14911-cit-0051"><string-name name-style="western"><surname>Ho</surname><given-names>KW</given-names></string-name>, <string-name name-style="western"><surname>Ward</surname><given-names>NJ</given-names></string-name>, <string-name name-style="western"><surname>Calkins</surname><given-names>DJ</given-names></string-name>. <article-title>TRPV1: a stress response protein in the central nervous system</article-title>. <source>Am J Neurodegener Dis</source>. <year>2012</year>;<volume>1</volume>(<issue>1</issue>):<fpage>1</fpage>&#8208;<lpage>14</lpage>.<pub-id pub-id-type="pmid">22737633</pub-id><pub-id pub-id-type="pmcid">PMC3560445</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="nmo14911-cit-0052"><string-name name-style="western"><surname>Marsch</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Foeller</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Rammes</surname><given-names>G</given-names></string-name>, et&#160;al. <article-title>Reduced anxiety, conditioned fear, and hippocampal long&#8208;term potentiation in transient receptor potential vanilloid type 1 receptor&#8208;deficient mice</article-title>. <source>J Neurosci</source>. <year>2007</year>;<volume>27</volume>(<issue>4</issue>):<fpage>832</fpage>&#8208;<lpage>839</lpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3303-06.2007</pub-id><pub-id pub-id-type="pmid">17251423</pub-id><pub-id pub-id-type="pmcid">PMC6672910</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="nmo14911-cit-0053"><string-name name-style="western"><surname>Navarria</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Tamburella</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Iannotti</surname><given-names>FA</given-names></string-name>, et&#160;al. <article-title>The dual blocker of FAAH/TRPV1 <italic toggle="yes">N</italic>&#8208;arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA&#8208;axis</article-title>. <source>Pharmacol Res</source>. <year>2014</year>;<volume>87</volume>:<fpage>151</fpage>&#8208;<lpage>159</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.phrs.2014.04.014</pub-id><pub-id pub-id-type="pmid">24861565</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="nmo14911-cit-0054"><string-name name-style="western"><surname>Pavlov</surname><given-names>VM</given-names></string-name>, <string-name name-style="western"><surname>Fedotova</surname><given-names>AY</given-names></string-name>, <string-name name-style="western"><surname>Andreev</surname><given-names>YA</given-names></string-name>, <string-name name-style="western"><surname>Palikov</surname><given-names>VA</given-names></string-name>, <string-name name-style="western"><surname>Dyachenko</surname><given-names>IA</given-names></string-name>. <article-title>The study of TRPV1 channels of the central nervous system and their effect on anxiety in ICR mice</article-title>. <source>Dokl Biochem Biophys</source>. <year>2024</year>:<fpage>1</fpage>&#8208;<lpage>4</lpage>. doi:<pub-id pub-id-type="doi">10.1134/S1607672924600325</pub-id><pub-id pub-id-type="pmid">39023670</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="nmo14911-cit-0055"><string-name name-style="western"><surname>Puder</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Weidenfeld</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Chowers</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Nir</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Conforti</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Siegel</surname><given-names>RA</given-names></string-name>. <article-title>Corticotrophin and corticosterone secretion following &#916;1&#8208;tetrahydrocannabinol, in intact and in hypothalamic deafferentated male rats</article-title>. <source>Exp Brain Res</source>. <year>1982</year>;<volume>46</volume>(<issue>1</issue>):<fpage>85</fpage>&#8208;<lpage>88</lpage>. doi:<pub-id pub-id-type="doi">10.1007/BF00238101</pub-id><pub-id pub-id-type="pmid">6279428</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="nmo14911-cit-0056"><string-name name-style="western"><surname>McLaughlin</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Hill</surname><given-names>MN</given-names></string-name>, <string-name name-style="western"><surname>Gorzalka</surname><given-names>BB</given-names></string-name>. <article-title>Monoaminergic neurotransmission contributes to cannabinoid&#8208;induced activation of the hypothalamic&#8208;pituitary&#8208;adrenal axis</article-title>. <source>Eur J Pharmacol</source>. <year>2009</year>;<volume>624</volume>:<fpage>71</fpage>&#8208;<lpage>76</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ejphar.2009.09.055</pub-id><pub-id pub-id-type="pmid">19818759</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="nmo14911-cit-0057"><string-name name-style="western"><surname>Papini</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ruglass</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Lopez&#8208;Castro</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Powers</surname><given-names>MB</given-names></string-name>, <string-name name-style="western"><surname>Smits</surname><given-names>JAJ</given-names></string-name>, <string-name name-style="western"><surname>Hien</surname><given-names>DA</given-names></string-name>. <article-title>Chronic cannabis use is associated with impaired fear extinction in humans</article-title>. <source>J Abnorm Psychol</source>. <year>2017</year>;<volume>126</volume>(<issue>1</issue>):<fpage>117</fpage>&#8208;<lpage>124</lpage>. doi:<pub-id pub-id-type="doi">10.1037/abn0000224</pub-id><pub-id pub-id-type="pmid">27808542</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="nmo14911-cit-0058"><string-name name-style="western"><surname>DeVuono</surname><given-names>MV</given-names></string-name>, <string-name name-style="western"><surname>La Caprara</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Sullivan</surname><given-names>MT</given-names></string-name>, et&#160;al. <article-title>Role of the stress response and the endocannabinoid system in &#916;9&#8208;tetrahydrocannabinol (THC)&#8208;induced nausea</article-title>. <source>Psychopharmacology (Berl)</source>. <year>2020</year>;<volume>237</volume>:<fpage>2187</fpage>&#8208;<lpage>2199</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00213-020-05529-5</pub-id><pub-id pub-id-type="pmid">32399633</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0059"><label>59</label><mixed-citation publication-type="journal" id="nmo14911-cit-0059"><string-name name-style="western"><surname>DeVuono</surname><given-names>MV</given-names></string-name>, <string-name name-style="western"><surname>Hrelja</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Petrie</surname><given-names>GN</given-names></string-name>, et&#160;al. <article-title>Nausea&#8208;induced conditioned gaping reactions in rats produced by high&#8208;dose synthetic cannabinoid, JWH&#8208;018</article-title>. <source>Cannabis Cannabinoid Res</source>. <year>2020</year>;<volume>5</volume>(<issue>4</issue>):<fpage>298</fpage>&#8208;<lpage>304</lpage>. doi:<pub-id pub-id-type="doi">10.1089/can.2019.0103</pub-id><pub-id pub-id-type="pmid">33381644</pub-id><pub-id pub-id-type="pmcid">PMC7759265</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0060"><label>60</label><mixed-citation publication-type="journal" id="nmo14911-cit-0060"><string-name name-style="western"><surname>Cuttler</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Spradlin</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Nusbaum</surname><given-names>AT</given-names></string-name>, <string-name name-style="western"><surname>Whitney</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Hinson</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>McLaughlin</surname><given-names>RJ</given-names></string-name>. <article-title>Blunted stress reactivity in chronic cannabis users</article-title>. <source>Psychopharmacology (Berl)</source>. <year>2017</year>;<volume>234</volume>(<issue>15</issue>):<fpage>2299</fpage>&#8208;<lpage>2309</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00213-017-4648-z</pub-id><pub-id pub-id-type="pmid">28567696</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0061"><label>61</label><mixed-citation publication-type="journal" id="nmo14911-cit-0061"><string-name name-style="western"><surname>Somaini</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Manfredini</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Amore</surname><given-names>M</given-names></string-name>, et&#160;al. <article-title>Psychobiological responses to unpleasant emotions in cannabis users</article-title>. <source>Eur Arch Psychiatry Clin Neurosci</source>. <year>2012</year>;<volume>262</volume>(<issue>1</issue>):<fpage>47</fpage>&#8208;<lpage>57</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00406-011-0223-5</pub-id><pub-id pub-id-type="pmid">21773812</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0062"><label>62</label><mixed-citation publication-type="journal" id="nmo14911-cit-0062"><string-name name-style="western"><surname>Alshaarawy</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Elbaz</surname><given-names>HA</given-names></string-name>. <article-title>Cannabis use and blood pressure levels: United States national health and nutrition examination survey, 2005&#8208;2012</article-title>. <source>J Hypertens</source>. <year>2016</year>;<volume>34</volume>(<issue>8</issue>):<fpage>1507</fpage>&#8208;<lpage>1512</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.physbeh.2017.03.040</pub-id><pub-id pub-id-type="pmid">27270185</pub-id><pub-id pub-id-type="pmcid">PMC5237375</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0063"><label>63</label><mixed-citation publication-type="journal" id="nmo14911-cit-0063"><string-name name-style="western"><surname>Venkatesan</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Zadvornova</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Raff</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Hillard</surname><given-names>CJ</given-names></string-name>. <article-title>Endocannabinoid&#8208;related lipids are increased during an episode of cyclic vomiting syndrome</article-title>. <source>Neurogastroenterol Motil</source>. <year>2016</year>;<volume>28</volume>(<issue>9</issue>):<fpage>1409</fpage>&#8208;<lpage>1418</lpage>. doi:<pub-id pub-id-type="doi">10.1111/nmo.12843</pub-id><pub-id pub-id-type="pmid">27098832</pub-id><pub-id pub-id-type="pmcid">PMC5002231</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0064"><label>64</label><mixed-citation publication-type="journal" id="nmo14911-cit-0064"><string-name name-style="western"><surname>Shah</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Jergel</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>George</surname><given-names>RP</given-names></string-name>, <string-name name-style="western"><surname>Jenkins</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Bashaw</surname><given-names>H</given-names></string-name>. <article-title>Distinguishing clinical features of cannabinoid hyperemesis syndrome and cyclic vomiting syndrome: a retrospective cohort study</article-title>. <source>J Pediatr</source>. <year>2024</year>;<volume>271</volume>:<elocation-id>114054</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.jpeds.2024.114054</pub-id><pub-id pub-id-type="pmid">38615942</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0065"><label>65</label><mixed-citation publication-type="journal" id="nmo14911-cit-0065"><string-name name-style="western"><surname>Patel</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hillard</surname><given-names>CJ</given-names></string-name>. <article-title>Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid</article-title>. <source>J Pharmacol Exp Ther</source>. <year>2006</year>;<volume>318</volume>(<issue>1</issue>):<fpage>304</fpage>&#8208;<lpage>311</lpage>. doi:<pub-id pub-id-type="doi">10.1124/jpet.106.101287</pub-id><pub-id pub-id-type="pmid">16569753</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0066"><label>66</label><mixed-citation publication-type="journal" id="nmo14911-cit-0066"><string-name name-style="western"><surname>Rey</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>Purrio</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Viveros</surname><given-names>MP</given-names></string-name>, <string-name name-style="western"><surname>Lutz</surname><given-names>B</given-names></string-name>. <article-title>Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA B receptors in the balance of GABAergic and glutamatergic neurotransmission</article-title>. <source>Neuropsychopharmacology</source>. <year>2012</year>;<volume>37</volume>(<issue>10</issue>):<fpage>2624</fpage>&#8208;<lpage>2634</lpage>. doi:<pub-id pub-id-type="doi">10.1038/npp.2012.123</pub-id><pub-id pub-id-type="pmid">22850737</pub-id><pub-id pub-id-type="pmcid">PMC3473327</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0067"><label>67</label><mixed-citation publication-type="journal" id="nmo14911-cit-0067"><string-name name-style="western"><surname>Romero</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Berrendero</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Manzanares</surname><given-names>J</given-names></string-name>, et&#160;al. <article-title>Time&#8208;course of the cannabinoid receptor down&#8208;regulation in the adult rat brain caused by repeated exposure to delta9&#8208;tetrahydrocannabinol</article-title>. <source>Synapse</source>. <year>1998</year>;<volume>30</volume>(<issue>3</issue>):<fpage>298</fpage>&#8208;<lpage>308</lpage>.<pub-id pub-id-type="pmid">9776133</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(SICI)1098-2396(199811)30:3&lt;298::AID-SYN7&gt;3.0.CO;2-6</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0068"><label>68</label><mixed-citation publication-type="journal" id="nmo14911-cit-0068"><string-name name-style="western"><surname>Rubino</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Vigan&#242;</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Premoli</surname><given-names>F</given-names></string-name>, et&#160;al. <article-title>Changes in the expression of G protein&#8208;coupled receptor kinases and beta&#8208;arrestins in mouse brain during cannabinoid tolerance</article-title>. <source>Mol Neurobiol</source>. <year>2006</year>;<volume>33</volume>(<issue>3</issue>):<fpage>199</fpage>&#8208;<lpage>213</lpage>. doi:<pub-id pub-id-type="doi">10.1385/MN:33:3:199</pub-id><pub-id pub-id-type="pmid">16954596</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0069"><label>69</label><mixed-citation publication-type="journal" id="nmo14911-cit-0069"><string-name name-style="western"><surname>Sim</surname><given-names>LJ</given-names></string-name>, <string-name name-style="western"><surname>Hampson</surname><given-names>RE</given-names></string-name>, <string-name name-style="western"><surname>Deadwyler</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Childers</surname><given-names>SR</given-names></string-name>. <article-title>Effects of chronic treatment with delta9&#8208;tetrahydrocannabinol on cannabinoid&#8208;stimulated [35S]GTPgammaS autoradiography in rat brain</article-title>. <source>J Neurosci</source>. <year>1996</year>;<volume>16</volume>(<issue>24</issue>):<fpage>8057</fpage>&#8208;<lpage>8066</lpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.16-24-08057.1996</pub-id><pub-id pub-id-type="pmid">8987831</pub-id><pub-id pub-id-type="pmcid">PMC6579228</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0070"><label>70</label><mixed-citation publication-type="journal" id="nmo14911-cit-0070"><string-name name-style="western"><surname>Zhuang</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Kittler</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Grigorenko</surname><given-names>EV</given-names></string-name>, et&#160;al. <article-title>Effects of long&#8208;term exposure to delta9&#8208;THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions</article-title>. <source>Mol Brain Res</source>. <year>1998</year>;<volume>62</volume>:<fpage>141</fpage>&#8208;<lpage>149</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0169-328X(98)00232-0</pub-id><pub-id pub-id-type="pmid">9813289</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0071"><label>71</label><mixed-citation publication-type="journal" id="nmo14911-cit-0071"><string-name name-style="western"><surname>McLaughlin</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Hill</surname><given-names>MN</given-names></string-name>, <string-name name-style="western"><surname>Bambico</surname><given-names>FR</given-names></string-name>, et&#160;al. <article-title>Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway</article-title>. <source>Eur Neuropsychopharmacol</source>. <year>2012</year>;<volume>22</volume>(<issue>9</issue>):<fpage>664</fpage>&#8208;<lpage>671</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.euroneuro.2012.01.004</pub-id><pub-id pub-id-type="pmid">22325231</pub-id><pub-id pub-id-type="pmcid">PMC3366159</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0072"><label>72</label><mixed-citation publication-type="journal" id="nmo14911-cit-0072"><string-name name-style="western"><surname>Tai</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hyatt</surname><given-names>WS</given-names></string-name>, <string-name name-style="western"><surname>Gu</surname><given-names>C</given-names></string-name>, et&#160;al. <article-title>Repeated administration of phytocannabinoid &#916;9&#8208;THC or synthetic cannabinoids JWH&#8208;018 and JWH&#8208;073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region&#8208;specific manner</article-title>. <source>Pharmacol Res</source>. <year>2015</year>;<volume>102</volume>:<fpage>22</fpage>&#8208;<lpage>32</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.phrs.2015.09.006</pub-id><pub-id pub-id-type="pmid">26361728</pub-id><pub-id pub-id-type="pmcid">PMC4684449</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0073"><label>73</label><mixed-citation publication-type="journal" id="nmo14911-cit-0073"><string-name name-style="western"><surname>DeVuono</surname><given-names>MV</given-names></string-name>, <string-name name-style="western"><surname>Hrelja</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Sabaziotis</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>Conditioned gaping produced by high dose &#916;9&#8208;tetrahydrocannabinol: dysregulation of the hypothalamic endocannabinoid system</article-title>. <source>Neuropharmacology</source>. <year>2018</year>;<volume>141</volume>:<fpage>272</fpage>&#8208;<lpage>282</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuropharm.2018.08.039</pub-id><pub-id pub-id-type="pmid">30195587</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0074"><label>74</label><mixed-citation publication-type="journal" id="nmo14911-cit-0074"><string-name name-style="western"><surname>Breivogel</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Scates</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Beletskaya</surname><given-names>IO</given-names></string-name>, <string-name name-style="western"><surname>Lowery</surname><given-names>OB</given-names></string-name>, <string-name name-style="western"><surname>Aceto</surname><given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Martin</surname><given-names>BR</given-names></string-name>. <article-title>The effects of &#916;9&#8208;tetrahydrocannabinol physical dependence on brain cannabinoid receptors</article-title>. <source>Eur J Pharmacol</source>. <year>2003</year>;<volume>459</volume>:<fpage>139</fpage>&#8208;<lpage>150</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0014-2999(02)02854-6</pub-id><pub-id pub-id-type="pmid">12524139</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0075"><label>75</label><mixed-citation publication-type="journal" id="nmo14911-cit-0075"><string-name name-style="western"><surname>Dalton</surname><given-names>VS</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Zavitsanou</surname><given-names>K</given-names></string-name>. <article-title>HU210&#8208;induced downregulation in cannabinoid CB1 receptor binding strongly correlates with body weight loss in the adult rat</article-title>. <source>Neurochem Res</source>. <year>2009</year>;<volume>34</volume>(<issue>7</issue>):<fpage>1343</fpage>&#8208;<lpage>1353</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11064-009-9914-y</pub-id><pub-id pub-id-type="pmid">19169813</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0076"><label>76</label><mixed-citation publication-type="journal" id="nmo14911-cit-0076"><string-name name-style="western"><surname>Breivogel</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Childers</surname><given-names>SR</given-names></string-name>, <string-name name-style="western"><surname>Deadwyler</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Hampson</surname><given-names>RE</given-names></string-name>, <string-name name-style="western"><surname>Vogt</surname><given-names>LJ</given-names></string-name>, <string-name name-style="western"><surname>Sim&#8208;selley</surname><given-names>LJ</given-names></string-name>. <article-title>Chronic delta&#8208;9 &#8208;tetrahydrocannabinol treatment produces a time&#8208; dependent loss of cannabinoid receptors and cannabinoid receptor&#8208;activated G proteins in rat brain</article-title>. <source>J Neurochem</source>. <year>1999</year>;<volume>73</volume>(<issue>6</issue>):<fpage>2447</fpage>&#8208;<lpage>2459</lpage>.<pub-id pub-id-type="pmid">10582605</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1471-4159.1999.0732447.x</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0077"><label>77</label><mixed-citation publication-type="journal" id="nmo14911-cit-0077"><string-name name-style="western"><surname>Sim&#8208;Selley</surname><given-names>LJ</given-names></string-name>, <string-name name-style="western"><surname>Schechter</surname><given-names>NS</given-names></string-name>, <string-name name-style="western"><surname>Rorrer</surname><given-names>WK</given-names></string-name>, et&#160;al. <article-title>Prolonged recovery rate of CB1 receptor adaptation after cessation of Long&#8208;term cannabinoid administration</article-title>. <source>Mol PharmacolMol Pharmacol</source>. <year>2006</year>;<volume>70</volume>(<issue>3</issue>):<fpage>986</fpage>&#8208;<lpage>996</lpage>. doi:<pub-id pub-id-type="doi">10.1124/mol.105.019612</pub-id><pub-id pub-id-type="pmid">16760363</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0078"><label>78</label><mixed-citation publication-type="journal" id="nmo14911-cit-0078"><string-name name-style="western"><surname>Hirvonen</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Goodwin</surname><given-names>RS</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>CT</given-names></string-name>, et&#160;al. <article-title>Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers</article-title>. <source>Mol Psychiatry</source>. <year>2012</year>;<volume>17</volume>(<issue>6</issue>):<fpage>642</fpage>&#8208;<lpage>649</lpage>. doi:<pub-id pub-id-type="doi">10.1038/mp.2011.82</pub-id><pub-id pub-id-type="pmid">21747398</pub-id><pub-id pub-id-type="pmcid">PMC3223558</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0079"><label>79</label><mixed-citation publication-type="journal" id="nmo14911-cit-0079"><string-name name-style="western"><surname>Morgan</surname><given-names>CJA</given-names></string-name>, <string-name name-style="western"><surname>Page</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Schaefer</surname><given-names>C</given-names></string-name>, et&#160;al. <article-title>Cerebrospinal fluid anandamide levels, cannabis use and psychotic&#8208;like symptoms</article-title>. <source>Br J Psychiatry</source>. <year>2013</year>;<volume>202</volume>(<issue>5</issue>):<fpage>381</fpage>&#8208;<lpage>382</lpage>. doi:<pub-id pub-id-type="doi">10.1192/bjp.bp.112.121178</pub-id><pub-id pub-id-type="pmid">23580381</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0080"><label>80</label><mixed-citation publication-type="journal" id="nmo14911-cit-0080"><string-name name-style="western"><surname>Ceccarini</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kuepper</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Kemels</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>van Os</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Henquet</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Van Laere</surname><given-names>K</given-names></string-name>. <article-title>[18F]MK&#8208;9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users</article-title>. <source>Addict Biol</source>. <year>2015</year>;<volume>20</volume>(<issue>2</issue>):<fpage>357</fpage>&#8208;<lpage>367</lpage>. doi:<pub-id pub-id-type="doi">10.1111/adb.12116</pub-id><pub-id pub-id-type="pmid">24373053</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0081"><label>81</label><mixed-citation publication-type="journal" id="nmo14911-cit-0081"><string-name name-style="western"><surname>D'Souza</surname><given-names>DC</given-names></string-name>, <string-name name-style="western"><surname>Cortes&#8208;Briones</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Creatura</surname><given-names>G</given-names></string-name>, et&#160;al. <article-title>Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF&#8208;04457845) in the treatment of cannabis withdrawal and dependence in men: a double&#8208;blind, placebo&#8208;controlled, parallel group, phase 2a single&#8208;site randomised controlled trial</article-title>. <source>Lancet Psychiatry</source>. <year>2019</year>;<volume>6</volume>(<issue>1</issue>):<fpage>35</fpage>&#8208;<lpage>45</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S2215-0366(18)30427-9</pub-id><pub-id pub-id-type="pmid">30528676</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0082"><label>82</label><mixed-citation publication-type="journal" id="nmo14911-cit-0082"><string-name name-style="western"><surname>Gorzalka</surname><given-names>BB</given-names></string-name>, <string-name name-style="western"><surname>Hill</surname><given-names>MN</given-names></string-name>, <string-name name-style="western"><surname>Hillard</surname><given-names>CJ</given-names></string-name>. <article-title>Regulation of endocannabinoid signaling by stress: implications for stress&#8208;related affective disorders</article-title>. <source>Neurosci Biobehav Rev</source>. <year>2008</year>;<volume>32</volume>(<issue>6</issue>):<fpage>1152</fpage>&#8208;<lpage>1160</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neubiorev.2008.03.004</pub-id><pub-id pub-id-type="pmid">18433869</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0083"><label>83</label><mixed-citation publication-type="journal" id="nmo14911-cit-0083"><string-name name-style="western"><surname>Zorn</surname><given-names>JV</given-names></string-name>, <string-name name-style="western"><surname>Sch&#252;r</surname><given-names>RR</given-names></string-name>, <string-name name-style="western"><surname>Boks</surname><given-names>MP</given-names></string-name>, <string-name name-style="western"><surname>Kahn</surname><given-names>RS</given-names></string-name>, <string-name name-style="western"><surname>Jo&#235;ls</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Vinkers</surname><given-names>CH</given-names></string-name>. <article-title>Psychoneuroendocrinology cortisol stress reactivity across psychiatric disorders: a systematic review and meta&#8208;analysis</article-title>. <source>Psychoneuroendocrinology</source>. <year>2017</year>;<volume>77</volume>:<fpage>25</fpage>&#8208;<lpage>36</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.psyneuen.2016.11.036</pub-id><pub-id pub-id-type="pmid">28012291</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0084"><label>84</label><mixed-citation publication-type="journal" id="nmo14911-cit-0084"><string-name name-style="western"><surname>Hill</surname><given-names>MN</given-names></string-name>, <string-name name-style="western"><surname>Patel</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Carrier</surname><given-names>EJ</given-names></string-name>, et&#160;al. <article-title>Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress</article-title>. <source>Neuropsychopharmacology</source>. <year>2005</year>;<volume>30</volume>(<issue>3</issue>):<fpage>508</fpage>&#8208;<lpage>515</lpage>. doi:<pub-id pub-id-type="doi">10.1038/sj.npp.1300601</pub-id><pub-id pub-id-type="pmid">15525997</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0085"><label>85</label><mixed-citation publication-type="journal" id="nmo14911-cit-0085"><string-name name-style="western"><surname>Meiri</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Jhangiani</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Vredenburgh</surname><given-names>JJ</given-names></string-name>, et&#160;al. <article-title>Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy&#8208;induced nausea and vomiting</article-title>. <source>Curr Med Res Opin</source>. <year>2007</year>;<volume>23</volume>(<issue>3</issue>):<fpage>533</fpage>&#8208;<lpage>543</lpage>. doi:<pub-id pub-id-type="doi">10.1185/030079907X167525</pub-id><pub-id pub-id-type="pmid">17355735</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0086"><label>86</label><mixed-citation publication-type="journal" id="nmo14911-cit-0086"><string-name name-style="western"><surname>May</surname><given-names>MB</given-names></string-name>, <string-name name-style="western"><surname>Glode</surname><given-names>AE</given-names></string-name>. <article-title>Dronabinol for chemotherapy&#8208;induced nausea and vomiting unresponsive to antiemetics</article-title>. <source>Cancer Manag Res</source>. <year>2016</year>;<volume>8</volume>:<fpage>49</fpage>&#8208;<lpage>55</lpage>. doi:<pub-id pub-id-type="doi">10.2147/CMAR.S81425</pub-id><pub-id pub-id-type="pmid">27274310</pub-id><pub-id pub-id-type="pmcid">PMC4869612</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0087"><label>87</label><mixed-citation publication-type="journal" id="nmo14911-cit-0087"><string-name name-style="western"><surname>Hornby</surname><given-names>PJ</given-names></string-name>. <article-title>Central neurocircuitry associated with emesis</article-title>. <source>Am J Med</source>. <year>2001</year>;<volume>111</volume>(<issue>8</issue>):<fpage>106</fpage>&#8208;<lpage>112</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0002-9343(01)00849-X</pub-id><pub-id pub-id-type="pmid">11749934</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0088"><label>88</label><mixed-citation publication-type="journal" id="nmo14911-cit-0088"><string-name name-style="western"><surname>Irizarry</surname><given-names>KJL</given-names></string-name>, <string-name name-style="western"><surname>Zhong</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Kronmiller</surname><given-names>BA</given-names></string-name>, <string-name name-style="western"><surname>Darmani</surname><given-names>NA</given-names></string-name>. <article-title>RNA sequencing least shrew (<italic toggle="yes">Cryptotis parva</italic>) brainstem and gut transcripts following administration of a selective substance P neurokinin NK1 receptor agonist and antagonist expands genomics resources for emesis research</article-title>. <source>Front Genet</source>. <year>2023</year>;<volume>14</volume>:<elocation-id>975087</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fgene.2023.975087</pub-id><pub-id pub-id-type="pmid">36865388</pub-id><pub-id pub-id-type="pmcid">PMC9972295</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0089"><label>89</label><mixed-citation publication-type="journal" id="nmo14911-cit-0089"><string-name name-style="western"><surname>Horn</surname><given-names>CC</given-names></string-name>, <string-name name-style="western"><surname>Richardson</surname><given-names>EJ</given-names></string-name>, <string-name name-style="western"><surname>Andrews</surname><given-names>PLR</given-names></string-name>, <string-name name-style="western"><surname>Friedman</surname><given-names>MI</given-names></string-name>. <article-title>Differential effects on gastrointestinal and hepatic vagal afferent fibers in the rat by the anti&#8208;cancer agent cisplatin</article-title>. <source>Auton Neurosci</source>. <year>2004</year>;<volume>115</volume>(<issue>1&#8211;2</issue>):<fpage>74</fpage>&#8208;<lpage>81</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.autneu.2004.08.011</pub-id><pub-id pub-id-type="pmid">15507408</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0090"><label>90</label><mixed-citation publication-type="journal" id="nmo14911-cit-0090"><string-name name-style="western"><surname>Darmani</surname><given-names>NA</given-names></string-name>. <article-title>Delta&#8208;9&#8208;tetrahydrocannabinol differentially suppresses cisplatin&#8208;induced emesis and indices of motor function via cannabinoid CB1 receptors in the least shrew</article-title>. <source>Pharmacol Biochem Behav</source>. <year>2001</year>;<volume>69</volume>:<fpage>239</fpage>&#8208;<lpage>249</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0091-3057(01)00531-7</pub-id><pub-id pub-id-type="pmid">11420092</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0091"><label>91</label><mixed-citation publication-type="journal" id="nmo14911-cit-0091"><string-name name-style="western"><surname>Darmani</surname><given-names>NA</given-names></string-name>, <string-name name-style="western"><surname>Janoyan</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Crim</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ramirez</surname><given-names>J</given-names></string-name>. <article-title>Receptor mechanism and antiemetic activity of structurally&#8208;diverse cannabinoids against radiation&#8208;induced emesis in the least shrew</article-title>. <source>Eur J Pharmacol</source>. <year>2007</year>;<volume>563</volume>(<issue>1&#8211;3</issue>):<fpage>187</fpage>&#8208;<lpage>196</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ejphar.2007.01.093</pub-id><pub-id pub-id-type="pmid">17362921</pub-id><pub-id pub-id-type="pmcid">PMC1949344</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0092"><label>92</label><mixed-citation publication-type="journal" id="nmo14911-cit-0092"><string-name name-style="western"><surname>Kwiatkowska</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Parker</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Burton</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Mechoulam</surname><given-names>R</given-names></string-name>. <article-title>A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin&#8208;induced emesis in the <italic toggle="yes">Suncus murinus</italic> (house musk shrew)</article-title>. <source>Psychopharmacology (Berl)</source>. <year>2004</year>;<volume>174</volume>(<issue>2</issue>):<fpage>254</fpage>&#8208;<lpage>259</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00213-003-1739-9</pub-id><pub-id pub-id-type="pmid">14740147</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0093"><label>93</label><mixed-citation publication-type="journal" id="nmo14911-cit-0093"><string-name name-style="western"><surname>Parker</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Kwiatkowska</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Burton</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Mechoulam</surname><given-names>R</given-names></string-name>. <article-title>Effect of cannabinoids on lithium&#8208;induced vomiting in the <italic toggle="yes">Suncus murinus</italic> (house musk shrew)</article-title>. <source>Psychopharmacology (Berl)</source>. <year>2004</year>;<volume>171</volume>:<fpage>156</fpage>&#8208;<lpage>161</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00213-003-1571-2</pub-id><pub-id pub-id-type="pmid">13680081</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0094"><label>94</label><mixed-citation publication-type="journal" id="nmo14911-cit-0094"><string-name name-style="western"><surname>Cluny</surname><given-names>NL</given-names></string-name>, <string-name name-style="western"><surname>Naylor</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Whittle</surname><given-names>BA</given-names></string-name>, <string-name name-style="western"><surname>Javid</surname><given-names>FA</given-names></string-name>. <article-title>The effects of cannabidiol and tetrahydrocannabinol on motion&#8208;induced emesis in <italic toggle="yes">Suncus murinus</italic>
</article-title>. <source>Basic Clin Paharmacol Toxicol</source>. <year>2008</year>;<volume>103</volume>:<fpage>150</fpage>&#8208;<lpage>156</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1742-7843.2008.00253.x</pub-id><pub-id pub-id-type="pmid">18816298</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0095"><label>95</label><mixed-citation publication-type="journal" id="nmo14911-cit-0095"><string-name name-style="western"><surname>Van Sickle</surname><given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Duncan</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Kingsley</surname><given-names>PJ</given-names></string-name>, et&#160;al. <article-title>Identification and functional characterization of brainstem cannabinoid CB2 receptors</article-title>. <source>Science</source>. <year>2005</year>;<volume>310</volume>(<issue>5746</issue>):<fpage>329</fpage>&#8208;<lpage>332</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1115740</pub-id><pub-id pub-id-type="pmid">16224028</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0096"><label>96</label><mixed-citation publication-type="journal" id="nmo14911-cit-0096"><string-name name-style="western"><surname>Parker</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Limebeer</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Rock</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Litt</surname><given-names>DL</given-names></string-name>, <string-name name-style="western"><surname>Kwiatkowska</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Piomelli</surname><given-names>D</given-names></string-name>. <article-title>The FAAH inhibitor URB&#8208;597 interferes with cisplatin&#8208; and nicotine&#8208;induced vomiting in the <italic toggle="yes">Suncus murinus</italic> (house musk shrew)</article-title>. <source>Physiol Behav</source>. <year>2009</year>;<volume>97</volume>(<issue>1</issue>):<fpage>121</fpage>&#8208;<lpage>124</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.physbeh.2009.02.014</pub-id><pub-id pub-id-type="pmid">19239915</pub-id><pub-id pub-id-type="pmcid">PMC3781595</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0097"><label>97</label><mixed-citation publication-type="journal" id="nmo14911-cit-0097"><string-name name-style="western"><surname>Sticht</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Long</surname><given-names>JZ</given-names></string-name>, <string-name name-style="western"><surname>Rock</surname><given-names>EM</given-names></string-name>, et&#160;al. <article-title>Inhibition of monoacylglycerol lipase attenuates vomiting in <italic toggle="yes">Suncus murinus</italic> and 2&#8208;arachidonoyl glycerol attenuates nausea in rats</article-title>. <source>Br J Pharmacol</source>. <year>2012</year>;<volume>165</volume>(<issue>8</issue>):<fpage>2425</fpage>&#8208;<lpage>2435</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1476-5381.2011.01407.x</pub-id><pub-id pub-id-type="pmid">21470205</pub-id><pub-id pub-id-type="pmcid">PMC3423233</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0098"><label>98</label><mixed-citation publication-type="journal" id="nmo14911-cit-0098"><string-name name-style="western"><surname>H&#228;ring</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Grieb</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Monory</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Lutz</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Moreira</surname><given-names>FA</given-names></string-name>. <article-title>Cannabinoid CB1 receptor in the modulation of stress coping behavior in mice: the role of serotonin and different forebrain neuronal subpopulations</article-title>. <source>Neuropharmacology</source>. <year>2013</year>;<volume>65</volume>:<fpage>83</fpage>&#8208;<lpage>89</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuropharm.2012.09.002</pub-id><pub-id pub-id-type="pmid">23000076</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0099"><label>99</label><mixed-citation publication-type="journal" id="nmo14911-cit-0099"><string-name name-style="western"><surname>H&#228;ring</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Marsicano</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Lutz</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Monory</surname><given-names>K</given-names></string-name>. <article-title>Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice</article-title>. <source>Neuroscience</source>. <year>2007</year>;<volume>146</volume>(<issue>3</issue>):<fpage>1212</fpage>&#8208;<lpage>1219</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroscience.2007.02.021</pub-id><pub-id pub-id-type="pmid">17383106</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0100"><label>100</label><mixed-citation publication-type="journal" id="nmo14911-cit-0100"><string-name name-style="western"><surname>Rudd</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Nalivaiko</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Matsuki</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Wan</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Andrews</surname><given-names>PLR</given-names></string-name>. <article-title>The involvement of TRPV1 in emesis and anti&#8208;emesis</article-title>. <source>Temperature</source>. <year>2015</year>;<volume>2</volume>(<issue>2</issue>):<fpage>258</fpage>&#8208;<lpage>276</lpage>. doi:<pub-id pub-id-type="doi">10.1080/23328940.2015.1043042</pub-id><pub-id pub-id-type="pmcid">PMC4843889</pub-id><pub-id pub-id-type="pmid">27227028</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0101"><label>101</label><mixed-citation publication-type="journal" id="nmo14911-cit-0101"><string-name name-style="western"><surname>Darmani</surname><given-names>NA</given-names></string-name>, <string-name name-style="western"><surname>Belkacemi</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Zhong</surname><given-names>W</given-names></string-name>. <article-title>&#916;9&#8208;THC and related cannabinoids suppress substance P&#8208; induced neurokinin NK1&#8208;receptor&#8208;mediated vomiting via activation of cannabinoid CB1 receptor</article-title>. <source>Eur J Pharmacol</source>. <year>2019</year>;<volume>865</volume>:<elocation-id>172806</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.ejphar.2019.172806</pub-id><pub-id pub-id-type="pmid">31738934</pub-id><pub-id pub-id-type="pmcid">PMC6910216</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0102"><label>102</label><mixed-citation publication-type="journal" id="nmo14911-cit-0102"><string-name name-style="western"><surname>Roscoe</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Morrow</surname><given-names>GR</given-names></string-name>, <string-name name-style="western"><surname>Hickok</surname><given-names>JT</given-names></string-name>, <string-name name-style="western"><surname>Stern</surname><given-names>RM</given-names></string-name>. <article-title>Nausea and vomiting remain a significant clinical problem: trends over time in controlling chemotherapy&#8208;induced nausea and vomiting in 1413 patients treated in community clinical practices</article-title>. <source>J Pain Symptom Manage</source>. <year>2000</year>;<volume>20</volume>(<issue>2</issue>):<fpage>113</fpage>&#8208;<lpage>121</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0885-3924(00)00159-7</pub-id><pub-id pub-id-type="pmid">10989249</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0103"><label>103</label><mixed-citation publication-type="journal" id="nmo14911-cit-0103"><string-name name-style="western"><surname>Andrews</surname><given-names>PLR</given-names></string-name>, <string-name name-style="western"><surname>Horn</surname><given-names>CC</given-names></string-name>. <article-title>Signals for nausea and emesis: implications for models of upper gastrointestinal diseases</article-title>. <source>Auton Neurosci</source>. <year>2006</year>;<volume>125</volume>(<issue>1&#8211;2</issue>):<fpage>100</fpage>&#8208;<lpage>115</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.autneu.2006.01.008</pub-id><pub-id pub-id-type="pmid">16556512</pub-id><pub-id pub-id-type="pmcid">PMC2658708</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0104"><label>104</label><mixed-citation publication-type="journal" id="nmo14911-cit-0104"><string-name name-style="western"><surname>Zhong</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Shahbaz</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Teskey</surname><given-names>G</given-names></string-name>, et&#160;al. <article-title>Mechanisms of nausea and vomiting: current knowledge and recent advances in intracellular emetic signaling systems</article-title>. <source>Int J Mol Sci</source>. <year>2021</year>;<volume>22</volume>(<issue>11</issue>):<elocation-id>5797</elocation-id>. doi:<pub-id pub-id-type="doi">10.3390/ijms22115797</pub-id><pub-id pub-id-type="pmid">34071460</pub-id><pub-id pub-id-type="pmcid">PMC8198651</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0105"><label>105</label><mixed-citation publication-type="journal" id="nmo14911-cit-0105"><string-name name-style="western"><surname>Tram&#232;r</surname><given-names>MR</given-names></string-name>, <string-name name-style="western"><surname>Carroll</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Campbell</surname><given-names>FA</given-names></string-name>, <string-name name-style="western"><surname>Reynolds</surname><given-names>DJM</given-names></string-name>, <string-name name-style="western"><surname>Moore</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>McQuay</surname><given-names>HJ</given-names></string-name>. <article-title>Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review</article-title>. <source>BMJ</source>. <year>2001</year>;<volume>323</volume>(<issue>7303</issue>):<fpage>16</fpage>&#8208;<lpage>21</lpage>. doi:<pub-id pub-id-type="doi">10.1136/bmj.323.7303.16</pub-id><pub-id pub-id-type="pmid">11440936</pub-id><pub-id pub-id-type="pmcid">PMC34325</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0106"><label>106</label><mixed-citation publication-type="journal" id="nmo14911-cit-0106"><string-name name-style="western"><surname>Santana</surname><given-names>TA</given-names></string-name>, <string-name name-style="western"><surname>Trufelli</surname><given-names>DC</given-names></string-name>, <string-name name-style="western"><surname>de Matos</surname><given-names>LL</given-names></string-name>, <string-name name-style="western"><surname>Cruz</surname><given-names>FM</given-names></string-name>, <string-name name-style="western"><surname>Del Giglio</surname><given-names>A</given-names></string-name>. <article-title>Meta&#8208;analysis of adjunctive non&#8208;NK1 receptor antagonist medications for the control of acute and delayed chemotherapy&#8208;induced nausea and vomiting</article-title>. <source>Support Care Cancer</source>. <year>2015</year>;<volume>23</volume>(<issue>1</issue>):<fpage>213</fpage>&#8208;<lpage>222</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00520-014-2392-z</pub-id><pub-id pub-id-type="pmid">25145507</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0107"><label>107</label><mixed-citation publication-type="journal" id="nmo14911-cit-0107"><string-name name-style="western"><surname>Stith</surname><given-names>SS</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Orozco</surname><given-names>J</given-names></string-name>, et&#160;al. <article-title>The effectiveness of common cannabis products for treatment of nausea</article-title>. <source>J Clin Gastroenterol</source>. <year>2022</year>;<volume>56</volume>(<issue>4</issue>):<fpage>331</fpage>&#8208;<lpage>338</lpage>. doi:<pub-id pub-id-type="doi">10.1097/MCG.0000000000001534</pub-id><pub-id pub-id-type="pmid">35258504</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0108"><label>108</label><mixed-citation publication-type="journal" id="nmo14911-cit-0108"><string-name name-style="western"><surname>Parker</surname><given-names>LA</given-names></string-name>. <article-title>Conditioned flavor avoidance and conditioned gaping: rat models of conditioned nausea</article-title>. <source>Eur J Pharmacol</source>. <year>2014</year>;<volume>722</volume>(<issue>1</issue>):<fpage>122</fpage>&#8208;<lpage>133</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ejphar.2013.09.070</pub-id><pub-id pub-id-type="pmid">24157975</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0109"><label>109</label><mixed-citation publication-type="journal" id="nmo14911-cit-0109"><string-name name-style="western"><surname>Grill</surname><given-names>HJ</given-names></string-name>, <string-name name-style="western"><surname>Norgren</surname><given-names>R</given-names></string-name>. <article-title>The taste reactivity test. I. Mimetic responses to gustatory stimuli in neurologically normal rats</article-title>. <source>Brain Res</source>. <year>1978</year>;<volume>143</volume>(<issue>2</issue>):<fpage>263</fpage>&#8208;<lpage>279</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0006-8993(78)90568-1</pub-id><pub-id pub-id-type="pmid">630409</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0110"><label>110</label><mixed-citation publication-type="journal" id="nmo14911-cit-0110"><string-name name-style="western"><surname>Travers</surname><given-names>JB</given-names></string-name>, <string-name name-style="western"><surname>Norgren</surname><given-names>R</given-names></string-name>. <article-title>Electromyographic analysis of the ingestion and rejection of sapid stimuli in the rat</article-title>. <source>Behav Neurosci</source>. <year>1986</year>;<volume>100</volume>(<issue>4</issue>):<fpage>544</fpage>&#8208;<lpage>555</lpage>. doi:<pub-id pub-id-type="doi">10.1037/0735-7044.100.4.544</pub-id><pub-id pub-id-type="pmid">3741605</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0111"><label>111</label><mixed-citation publication-type="journal" id="nmo14911-cit-0111"><string-name name-style="western"><surname>Napadow</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Sheehan</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>J</given-names></string-name>, et&#160;al. <article-title>The brain circuitry underlying the temporal evolution of nausea in humans</article-title>. <source>Cereb Cortex</source>. <year>2013</year>;<volume>23</volume>(<issue>4</issue>):<fpage>806</fpage>&#8208;<lpage>813</lpage>. doi:<pub-id pub-id-type="doi">10.1093/cercor/bhs073</pub-id><pub-id pub-id-type="pmid">22473843</pub-id><pub-id pub-id-type="pmcid">PMC3593575</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0112"><label>112</label><mixed-citation publication-type="journal" id="nmo14911-cit-0112"><string-name name-style="western"><surname>Sclocco</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Garcia</surname><given-names>RG</given-names></string-name>, et&#160;al. <article-title>Brain circuitry supporting multi&#8208;organ autonomic outflow in response to nausea</article-title>. <source>Cereb Cortex</source>. <year>2016</year>;<volume>26</volume>(<issue>2</issue>):<fpage>485</fpage>&#8208;<lpage>497</lpage>. doi:<pub-id pub-id-type="doi">10.1093/cercor/bhu172</pub-id><pub-id pub-id-type="pmid">25115821</pub-id><pub-id pub-id-type="pmcid">PMC4712791</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0113"><label>113</label><mixed-citation publication-type="journal" id="nmo14911-cit-0113"><string-name name-style="western"><surname>Aguilar&#8208;Rivera</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Coleman</surname><given-names>TP</given-names></string-name>, <string-name name-style="western"><surname>Maldonado</surname><given-names>PE</given-names></string-name>, <string-name name-style="western"><surname>Torrealba</surname><given-names>F</given-names></string-name>. <article-title>Interoceptive insular cortex participates in sensory processing of gastrointestinal malaise and associated behaviors</article-title>. <source>Sci Rep</source>. <year>2020</year>;<volume>10</volume>(<issue>1</issue>):<elocation-id>21642</elocation-id>. doi:<pub-id pub-id-type="doi">10.1038/s41598-020-78200-w</pub-id><pub-id pub-id-type="pmid">33303809</pub-id><pub-id pub-id-type="pmcid">PMC7730439</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0114"><label>114</label><mixed-citation publication-type="journal" id="nmo14911-cit-0114"><string-name name-style="western"><surname>Moldrich</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Wenger</surname><given-names>T</given-names></string-name>. <article-title>Localization of the CB1 cannabinoid receptor in the rat brain. An immunohistochemical study</article-title>. <source>Peptides</source>. <year>2000</year>;<volume>21</volume>(<issue>11</issue>):<fpage>1735</fpage>&#8208;<lpage>1742</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0196-9781(00)00324-7</pub-id><pub-id pub-id-type="pmid">11090929</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0115"><label>115</label><mixed-citation publication-type="journal" id="nmo14911-cit-0115"><string-name name-style="western"><surname>Hietala</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Nyman</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Eskola</surname><given-names>O</given-names></string-name>, et&#160;al. <article-title>Visualization and quantification of neurokinin&#8208;1 (NK1) receptors in the human brain</article-title>. <source>Mol Imaging Biol</source>. <year>2005</year>;<volume>7</volume>(<issue>4</issue>):<fpage>262</fpage>&#8208;<lpage>272</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11307-005-7001-6</pub-id><pub-id pub-id-type="pmid">16155744</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0116"><label>116</label><mixed-citation publication-type="journal" id="nmo14911-cit-0116"><string-name name-style="western"><surname>Allen</surname><given-names>GV</given-names></string-name>, <string-name name-style="western"><surname>Saper</surname><given-names>CB</given-names></string-name>, <string-name name-style="western"><surname>Hurley</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Cechetto</surname><given-names>DF</given-names></string-name>. <article-title>Organization of visceral and limbic connections in the insular cortex of the rat</article-title>. <source>J Comp Neurol</source>. <year>1991</year>;<volume>311</volume>(<issue>1</issue>):<fpage>1</fpage>&#8208;<lpage>16</lpage>. doi:<pub-id pub-id-type="doi">10.1002/cne.903110102</pub-id><pub-id pub-id-type="pmid">1719041</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0117"><label>117</label><mixed-citation publication-type="journal" id="nmo14911-cit-0117"><string-name name-style="western"><surname>Yasui</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Breder</surname><given-names>CD</given-names></string-name>, <string-name name-style="western"><surname>Saper</surname><given-names>CB</given-names></string-name>, <string-name name-style="western"><surname>Al</surname><given-names>YET</given-names></string-name>. <article-title>Autonomic responses and efferent pathways from the insular cortex in the rat</article-title>. <source>J Comp Neurol</source>. <year>1991</year>;<volume>303</volume>:<fpage>355</fpage>&#8208;<lpage>374</lpage>. doi:<pub-id pub-id-type="doi">10.1002/cne.903030303</pub-id><pub-id pub-id-type="pmid">2007654</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0118"><label>118</label><mixed-citation publication-type="journal" id="nmo14911-cit-0118"><string-name name-style="western"><surname>Limebeer</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Rock</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Sharkey</surname><given-names>KA</given-names></string-name>, <string-name name-style="western"><surname>Parker</surname><given-names>LA</given-names></string-name>. <article-title>Nausea&#8208;induced 5&#8208;HT release in the interoceptive insular cortex and regulation by monoacylglycerol lipase (MAGL) inhibition and cannabidiol</article-title>. <source>eNeuro</source>. <year>2018</year>;<volume>5</volume>(<issue>4</issue>):<fpage>1</fpage>&#8208;<lpage>10</lpage>. doi:<pub-id pub-id-type="doi">10.1523/ENEURO.0256-18.2018</pub-id><pub-id pub-id-type="pmcid">PMC6071201</pub-id><pub-id pub-id-type="pmid">30073198</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0119"><label>119</label><mixed-citation publication-type="journal" id="nmo14911-cit-0119"><string-name name-style="western"><surname>Tuerke</surname><given-names>KJ</given-names></string-name>, <string-name name-style="western"><surname>Limebeer</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Fletcher</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Parker</surname><given-names>LA</given-names></string-name>. <article-title>Double dissociation between regulation of conditioned disgust and taste avoidance by serotonin availability at the 5&#8208;HT3 receptor in the posterior and anterior insular cortex</article-title>. <source>J Neurosci</source>. <year>2012</year>;<volume>32</volume>(<issue>40</issue>):<fpage>13709</fpage>&#8208;<lpage>13717</lpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2042-12.2012</pub-id><pub-id pub-id-type="pmid">23035083</pub-id><pub-id pub-id-type="pmcid">PMC6704799</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0120"><label>120</label><mixed-citation publication-type="journal" id="nmo14911-cit-0120"><string-name name-style="western"><surname>Limebeer</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Parker</surname><given-names>LA</given-names></string-name>. <article-title>Delta&#8208;9&#8208;tetrahydrocannabinol interferes with the establishment and the expression of conditioned rejection reactions produced by cyclophosphamide: a rat model of nausea</article-title>. <source>Neuroreport</source>. <year>1999</year>;<volume>10</volume>:<fpage>3769</fpage>&#8208;<lpage>3772</lpage>.<pub-id pub-id-type="pmid">10716207</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00001756-199912160-00009</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0121"><label>121</label><mixed-citation publication-type="journal" id="nmo14911-cit-0121"><string-name name-style="western"><surname>Parker</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Mechoulam</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Schlievert</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Abbott</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Fudge</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Burton</surname><given-names>P</given-names></string-name>. <article-title>Effects of cannabinoids on lithium&#8208;induced conditioned rejection reactions in a rat model of nausea</article-title>. <source>Psychopharmacology (Berl)</source>. <year>2003</year>;<volume>166</volume>(<issue>2</issue>):<fpage>156</fpage>&#8208;<lpage>162</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00213-002-1329-2</pub-id><pub-id pub-id-type="pmid">12528012</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0122"><label>122</label><mixed-citation publication-type="journal" id="nmo14911-cit-0122"><string-name name-style="western"><surname>Limebeer</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Rock</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Mechoulam</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Parker</surname><given-names>LA</given-names></string-name>. <article-title>The anti&#8208;nausea effects of CB1 agonists are mediated by an action at the visceral insular cortex</article-title>. <source>Br J Pharmacol</source>. <year>2012</year>;<volume>167</volume>(<issue>5</issue>):<fpage>1126</fpage>&#8208;<lpage>1136</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1476-5381.2012.02066.x</pub-id><pub-id pub-id-type="pmid">22671779</pub-id><pub-id pub-id-type="pmcid">PMC3492992</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0123"><label>123</label><mixed-citation publication-type="journal" id="nmo14911-cit-0123"><string-name name-style="western"><surname>Parker</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Niphakis</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Downey</surname><given-names>R</given-names></string-name>, et&#160;al. <article-title>Effect of selective inhibition of monoacylglycerol lipase (MAGL) on acute nausea, anticipatory nausea, and vomiting in rats and Suncus murinus</article-title>. <source>Psychopharmacology (Berl)</source>. <year>2015</year>;<volume>232</volume>(<issue>3</issue>):<fpage>583</fpage>&#8208;<lpage>593</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00213-014-3696-x</pub-id><pub-id pub-id-type="pmid">25085768</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0124"><label>124</label><mixed-citation publication-type="journal" id="nmo14911-cit-0124"><string-name name-style="western"><surname>Sticht</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Limebeer</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Rafla</surname><given-names>BR</given-names></string-name>, et&#160;al. <article-title>Endocannabinoid regulation of nausea is mediated by 2&#8208;arachidonoylglycerol (2&#8208;AG) in the rat visceral insular cortex</article-title>. <source>Neuropharmachology</source>. <year>2016</year>;<volume>102</volume>:<fpage>92</fpage>&#8208;<lpage>102</lpage>. doi:<pub-id pub-id-type="doi">10.1245/s10434-014-3918-9</pub-id><pub-id pub-id-type="pmcid">PMC4698202</pub-id><pub-id pub-id-type="pmid">26541329</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0125"><label>125</label><mixed-citation publication-type="journal" id="nmo14911-cit-0125"><string-name name-style="western"><surname>Sticht</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Limebeer</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Rafla</surname><given-names>BR</given-names></string-name>, <string-name name-style="western"><surname>Parker</surname><given-names>LA</given-names></string-name>. <article-title>Intra&#8208;visceral insular cortex 2&#8208;arachidonoylglycerol, but not N&#8208;arachidonoylethanolamide, suppresses acute nausea&#8208;induced conditioned gaping in rats</article-title>. <source>Neuroscience</source>. <year>2015</year>;<volume>286</volume>:<fpage>338</fpage>&#8208;<lpage>344</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.neuroscience.2014.11.058</pub-id><pub-id pub-id-type="pmid">25499318</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0126"><label>126</label><mixed-citation publication-type="journal" id="nmo14911-cit-0126"><string-name name-style="western"><surname>Rock</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Limebeer</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Ward</surname><given-names>JM</given-names></string-name>, et&#160;al. <article-title>Interference with acute nausea and anticipatory nausea in rats by fatty acid amide hydrolase (FAAH) inhibition through a PPAR&#945; and CB1 receptor mechanism, respectively: a double dissociation</article-title>. <source>Psychopharmacology (Berl)</source>. <year>2015</year>;<volume>232</volume>(<issue>20</issue>):<fpage>3841</fpage>&#8208;<lpage>3848</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00213-015-4050-7</pub-id><pub-id pub-id-type="pmid">26297326</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0127"><label>127</label><mixed-citation publication-type="journal" id="nmo14911-cit-0127"><string-name name-style="western"><surname>Rock</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Moreno&#8208;Sanz</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Limebeer</surname><given-names>CL</given-names></string-name>, et&#160;al. <article-title>Suppression of acute and anticipatory nausea by peripherally restricted fatty acid amide hydrolase inhibitor in animal models: role of PPAR&#945; and CB1 receptors</article-title>. <source>Br J Pharmacol</source>. <year>2017</year>;<volume>174</volume>(<issue>21</issue>):<fpage>3837</fpage>&#8208;<lpage>3847</lpage>. doi:<pub-id pub-id-type="doi">10.1111/bph.13980</pub-id><pub-id pub-id-type="pmid">28805944</pub-id><pub-id pub-id-type="pmcid">PMC5647182</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0128"><label>128</label><mixed-citation publication-type="journal" id="nmo14911-cit-0128"><string-name name-style="western"><surname>Vaziri</surname><given-names>ND</given-names></string-name>, <string-name name-style="western"><surname>Thomas</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Stearling</surname><given-names>M</given-names></string-name>, et&#160;al. <article-title>Toxicity with intravenous injection of crude marijuana extract</article-title>. <source>Clin Toxicol</source>. <year>1981</year>;<volume>18</volume>(<issue>3</issue>):<fpage>353</fpage>&#8208;<lpage>366</lpage>.<pub-id pub-id-type="pmid">7237964</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/15563658108990042</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0129"><label>129</label><mixed-citation publication-type="journal" id="nmo14911-cit-0129"><string-name name-style="western"><surname>Ware</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Doyle</surname><given-names>CR</given-names></string-name>, <string-name name-style="western"><surname>Woods</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Lynch</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Clark</surname><given-names>AJ</given-names></string-name>. <article-title>Cannabis use for chronic non&#8208;cancer pain: results of a prospective survey</article-title>. <source>Pain</source>. <year>2003</year>;<volume>102</volume>(<issue>1</issue>):<fpage>211</fpage>&#8208;<lpage>216</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0304-3959(02)00400-1</pub-id><pub-id pub-id-type="pmid">12620613</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0130"><label>130</label><mixed-citation publication-type="journal" id="nmo14911-cit-0130"><string-name name-style="western"><surname>Karila</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Roux</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Rolland</surname><given-names>B</given-names></string-name>, et&#160;al. <article-title>Acute and long&#8208;term effects of cannabis use: a review</article-title>. <source>Curr Pharm Des</source>. <year>2014</year>;<volume>20</volume>:<fpage>4112</fpage>&#8208;<lpage>4118</lpage>.<pub-id pub-id-type="pmid">24001294</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/13816128113199990620</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0131"><label>131</label><mixed-citation publication-type="journal" id="nmo14911-cit-0131"><string-name name-style="western"><surname>Fallon</surname><given-names>MT</given-names></string-name>, <string-name name-style="western"><surname>Lux</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Mcquade</surname><given-names>R</given-names></string-name>, et&#160;al. <article-title>Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double&#8208;blind, randomized, placebo&#8208;controlled phase 3 studies</article-title>. <source>Br J Pain</source>. <year>2017</year>;<volume>11</volume>(<issue>3</issue>):<fpage>119</fpage>&#8208;<lpage>133</lpage>. doi:<pub-id pub-id-type="doi">10.1177/2049463717710042</pub-id><pub-id pub-id-type="pmid">28785408</pub-id><pub-id pub-id-type="pmcid">PMC5521351</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0132"><label>132</label><mixed-citation publication-type="journal" id="nmo14911-cit-0132"><string-name name-style="western"><surname>Johal</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Devji</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Simone</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Vannabouathong</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Bhandari</surname><given-names>M</given-names></string-name>. <article-title>Cannabinoids in chronic non&#8208;cancer pain: a systematic review and meta&#8208;analysis</article-title>. <source>Clin Med Insights Arthritis Musculoskelet Disord</source>. <year>2020</year>;<volume>13</volume>:<elocation-id>1179544120906461</elocation-id>. doi:<pub-id pub-id-type="doi">10.1177/1179544120906461</pub-id><pub-id pub-id-type="pmid">32127750</pub-id><pub-id pub-id-type="pmcid">PMC7031792</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0133"><label>133</label><mixed-citation publication-type="journal" id="nmo14911-cit-0133"><string-name name-style="western"><surname>Venkatesan</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Levinthal</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>BUK</given-names></string-name>, et&#160;al. <article-title>Role of chronic cannabis use: cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome</article-title>. <source>Neurogastroenterol Motil</source>. <year>2019</year>;<volume>31</volume>(<issue>S2</issue>):<elocation-id>e13606</elocation-id>. doi:<pub-id pub-id-type="doi">10.1111/nmo.13606</pub-id><pub-id pub-id-type="pmid">31241817</pub-id><pub-id pub-id-type="pmcid">PMC6788295</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0134"><label>134</label><mixed-citation publication-type="journal" id="nmo14911-cit-0134"><string-name name-style="western"><surname>Wasilewski</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Lewandowska</surname><given-names>U</given-names></string-name>, <string-name name-style="western"><surname>Mosinska</surname><given-names>P</given-names></string-name>, et&#160;al. <article-title>Cannabinoid receptor type 1 and mu&#8208;opioid receptor polymorphisms are associated with cyclic vomiting syndrome</article-title>. <source>Am J Gastroenterol</source>. <year>2017</year>;<volume>112</volume>(<issue>6</issue>):<fpage>933</fpage>&#8208;<lpage>939</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ajg.2017.73</pub-id><pub-id pub-id-type="pmid">28349993</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0135"><label>135</label><mixed-citation publication-type="journal" id="nmo14911-cit-0135"><string-name name-style="western"><surname>Scheckel</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Boff</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Dahlen</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Smart</surname><given-names>T</given-names></string-name>. <article-title>Behavioral effects in monkeys of racemates of two biologically active marijuana constituents</article-title>. <source>Science</source>. <year>1968</year>;<volume>160</volume>(<issue>3835</issue>):<fpage>1467</fpage>&#8208;<lpage>1469</lpage>.<pub-id pub-id-type="pmid">4968256</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.160.3835.1467</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0136"><label>136</label><mixed-citation publication-type="journal" id="nmo14911-cit-0136"><string-name name-style="western"><surname>Hockman</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Perrin</surname><given-names>RG</given-names></string-name>, <string-name name-style="western"><surname>Kalant</surname><given-names>H</given-names></string-name>. <article-title>Electroencephalographic and behavioral alterations produced by delta &#8208; 9&#8208;tetrahydrocannabinol</article-title>. <source>Science</source>. <year>1971</year>;<volume>172</volume>(<issue>3986</issue>):<fpage>968</fpage>&#8208;<lpage>970</lpage>.<pub-id pub-id-type="pmid">5573573</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.172.3986.968</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0137"><label>137</label><mixed-citation publication-type="journal" id="nmo14911-cit-0137"><string-name name-style="western"><surname>Shannon</surname><given-names>HE</given-names></string-name>, <string-name name-style="western"><surname>Martin</surname><given-names>WR</given-names></string-name>, <string-name name-style="western"><surname>Silcox</surname><given-names>D</given-names></string-name>. <article-title>Lack of antiemetic effects of delta&#8208;9&#8208;tetrahydrocannabinol in apomorphine&#8208;induced emesis in the dog</article-title>. <source>Life Sci</source>. <year>1978</year>;<volume>23</volume>:<fpage>49</fpage>&#8208;<lpage>53</lpage>.<pub-id pub-id-type="pmid">682866</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0024-3205(78)90324-7</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0138"><label>138</label><mixed-citation publication-type="journal" id="nmo14911-cit-0138"><string-name name-style="western"><surname>Parker</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Gillies</surname><given-names>T</given-names></string-name>. <article-title>THC&#8208;induced place and taste aversions in Lewis and Sprague&#8208;Dawley rats</article-title>. <source>Behav Neurosci</source>. <year>1995</year>;<volume>109</volume>(<issue>1</issue>):<fpage>71</fpage>&#8208;<lpage>78</lpage>.<pub-id pub-id-type="pmid">7734082</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1037//0735-7044.109.1.71</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0139"><label>139</label><mixed-citation publication-type="journal" id="nmo14911-cit-0139"><string-name name-style="western"><surname>Richards</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Gordon</surname><given-names>BK</given-names></string-name>, <string-name name-style="western"><surname>Danielson</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Moulin</surname><given-names>AK</given-names></string-name>. <article-title>Pharmacologic treatment of cannabinoid hyperemesis syndrome: a systematic review</article-title>. <source>Pharmacotherapy</source>. <year>2017</year>;<volume>37</volume>:<fpage>725</fpage>&#8208;<lpage>734</lpage>. doi:<pub-id pub-id-type="doi">10.1002/phar.1931</pub-id><pub-id pub-id-type="pmid">28370228</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0140"><label>140</label><mixed-citation publication-type="journal" id="nmo14911-cit-0140"><string-name name-style="western"><surname>Richards</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Dutczak</surname><given-names>O</given-names></string-name>. <article-title>Propranolol treatment of cannabinoid hyperemesis syndrome</article-title>. <source>J Clin Psychopharmacol</source>. <year>2017</year>;<volume>37</volume>(<issue>4</issue>):<fpage>482</fpage>&#8208;<lpage>484</lpage>. doi:<pub-id pub-id-type="doi">10.1097/JCP.0000000000000735</pub-id><pub-id pub-id-type="pmid">28604421</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0141"><label>141</label><mixed-citation publication-type="journal" id="nmo14911-cit-0141"><string-name name-style="western"><surname>Hayes</surname><given-names>WJ</given-names></string-name>, <string-name name-style="western"><surname>VanGilder</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Berendse</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Lemon</surname><given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Kappes</surname><given-names>JA</given-names></string-name>. <article-title>Cyclic vomiting syndrome: diagnostic approach and current management strategies</article-title>. <source>Clin Exp Gastroenterol</source>. <year>2018</year>;<volume>11</volume>:<fpage>77</fpage>&#8208;<lpage>84</lpage>.<pub-id pub-id-type="pmid">29520160</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/CEG.S136420</pub-id><pub-id pub-id-type="pmcid">PMC5833754</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0142"><label>142</label><mixed-citation publication-type="journal" id="nmo14911-cit-0142"><string-name name-style="western"><surname>Tarbell</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Shaltout</surname><given-names>HA</given-names></string-name>, <string-name name-style="western"><surname>Wagoner</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Diz</surname><given-names>DI</given-names></string-name>, <string-name name-style="western"><surname>Fortunato</surname><given-names>JE</given-names></string-name>. <article-title>Relationship among nausea, anxiety, and orthostatic symptoms in pediatric patients with chronic unexplained nausea</article-title>. <source>Exp Brain Res</source>. <year>2014</year>;<volume>232</volume>(<issue>8</issue>):<fpage>2645</fpage>&#8208;<lpage>2650</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00221-014-3981-2</pub-id><pub-id pub-id-type="pmid">24829068</pub-id><pub-id pub-id-type="pmcid">PMC7978495</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0143"><label>143</label><mixed-citation publication-type="journal" id="nmo14911-cit-0143"><string-name name-style="western"><surname>DeVuono</surname><given-names>MV</given-names></string-name>, <string-name name-style="western"><surname>Parker</surname><given-names>LA</given-names></string-name>. <article-title>Cannabinoid hyperemesis syndrome&#8201;: a review of potential mechanisms</article-title>. <source>Cannabis Cannabinoid Res</source>. <year>2020</year>;<volume>5</volume>:<fpage>132</fpage>&#8208;<lpage>144</lpage>. doi:<pub-id pub-id-type="doi">10.1089/can.2019.0059</pub-id><pub-id pub-id-type="pmid">32656345</pub-id><pub-id pub-id-type="pmcid">PMC7347072</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0144"><label>144</label><mixed-citation publication-type="journal" id="nmo14911-cit-0144"><string-name name-style="western"><surname>Andrykowski</surname><given-names>MA</given-names></string-name>. <article-title>The role of anxiety in the development of anticipatory nausea in cancer chemotherapy: a review and synthesis</article-title>. <source>Psychosom Med</source>. <year>1990</year>;<volume>52</volume>(<issue>4</issue>):<fpage>458</fpage>&#8208;<lpage>475</lpage>. doi:<pub-id pub-id-type="doi">10.1097/00006842-199007000-00008</pub-id><pub-id pub-id-type="pmid">2204952</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0145"><label>145</label><mixed-citation publication-type="journal" id="nmo14911-cit-0145"><string-name name-style="western"><surname>Levinthal</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Bielefeldt</surname><given-names>K</given-names></string-name>. <article-title>Adult cyclical vomiting syndrome: a disorder of allostatic regulation?</article-title><source>Exp Brain Res</source>. <year>2014</year>;<volume>232</volume>(<issue>8</issue>):<fpage>2541</fpage>&#8208;<lpage>2547</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00221-014-3939-4</pub-id><pub-id pub-id-type="pmid">24736863</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0146"><label>146</label><mixed-citation publication-type="journal" id="nmo14911-cit-0146"><string-name name-style="western"><surname>Mosa</surname><given-names>ASM</given-names></string-name>, <string-name name-style="western"><surname>Hossain</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Lavoie</surname><given-names>BJ</given-names></string-name>, <string-name name-style="western"><surname>Yoo</surname><given-names>I</given-names></string-name>. <article-title>Patient&#8208;related risk factors for chemotherapy&#8208;induced nausea and vomiting: a systematic review</article-title>. <source>Front Pharmacol</source>. <year>2020</year>;<volume>11</volume>:<elocation-id>329</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fphar.2020.00329</pub-id><pub-id pub-id-type="pmid">32296333</pub-id><pub-id pub-id-type="pmcid">PMC7138899</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0147"><label>147</label><mixed-citation publication-type="journal" id="nmo14911-cit-0147"><string-name name-style="western"><surname>Friesen</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Singh</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Singh</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Schurman</surname><given-names>JV</given-names></string-name>. <article-title>A cross&#8208;sectional study of nausea in functional abdominal pain: relation to mucosal mast cells and psychological functioning</article-title>. <source>BMC Gastroenterol</source>. <year>2020</year>;<volume>20</volume>(<issue>1</issue>):<elocation-id>144</elocation-id>. doi:<pub-id pub-id-type="doi">10.1186/s12876-020-01291-2</pub-id><pub-id pub-id-type="pmid">32393272</pub-id><pub-id pub-id-type="pmcid">PMC7216423</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0148"><label>148</label><mixed-citation publication-type="journal" id="nmo14911-cit-0148"><string-name name-style="western"><surname>Nguyen</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Wilson</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Miriel</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>Autonomic function in gastroparesis and chronic unexplained nausea and vomiting: relationship with etiology, gastric emptying, and symptom severity</article-title>. <source>Neurogastroenterol Motil</source>. <year>2020</year>;<volume>32</volume>:<elocation-id>e13810</elocation-id>. doi:<pub-id pub-id-type="doi">10.1111/nmo.13810</pub-id><pub-id pub-id-type="pmid">32061038</pub-id><pub-id pub-id-type="pmcid">PMC7377964</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0149"><label>149</label><mixed-citation publication-type="journal" id="nmo14911-cit-0149"><string-name name-style="western"><surname>Wilson</surname><given-names>PB</given-names></string-name>, <string-name name-style="western"><surname>Russell</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Pugh</surname><given-names>J</given-names></string-name>. <article-title>Anxiety may be a risk factor for experiencing gastrointestinal symptoms during endurance races: an observational study</article-title>. <source>Eur J Sport Sci</source>. <year>2021</year>;<volume>21</volume>(<issue>3</issue>):<fpage>421</fpage>&#8208;<lpage>427</lpage>. doi:<pub-id pub-id-type="doi">10.1080/17461391.2020.1746836</pub-id><pub-id pub-id-type="pmid">32251613</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0150"><label>150</label><mixed-citation publication-type="journal" id="nmo14911-cit-0150"><string-name name-style="western"><surname>Levinthal</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Romutis</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Rajalaban</surname><given-names>A</given-names></string-name>, et&#160;al. <article-title>Greater intolerance to uncertainty predicts poorer quality of life in adults with cyclic vomiting syndrome</article-title>. <source>Neurogastroenterol Motil</source>. <year>2021</year>;<volume>33</volume>(<issue>12</issue>):<elocation-id>e14159</elocation-id>. doi:<pub-id pub-id-type="doi">10.1111/nmo.14159</pub-id><pub-id pub-id-type="pmid">33830558</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0151"><label>151</label><mixed-citation publication-type="journal" id="nmo14911-cit-0151"><string-name name-style="western"><surname>P&#233;lissier</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Claudet</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Gandia&#8208;Mailly</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Benyamina</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Franchitto</surname><given-names>N</given-names></string-name>. <article-title>Cannabis hyperemesis syndrome in the emergency department: how can a specialized addiction team be useful? A pilot study</article-title>. <source>J Emerg Med</source>. <year>2016</year>;<volume>51</volume>(<issue>5</issue>):<fpage>544</fpage>&#8208;<lpage>551</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jemermed.2016.06.009</pub-id><pub-id pub-id-type="pmid">27485997</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0152"><label>152</label><mixed-citation publication-type="journal" id="nmo14911-cit-0152"><string-name name-style="western"><surname>Bhandari</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Venkatesan</surname><given-names>T</given-names></string-name>. <article-title>Clinical characteristics, comorbidities and hospital outcomes in hospitalizations with cyclic vomiting syndrome: a Nationwide analysis</article-title>. <source>Dig Dis Sci</source>. <year>2017</year>;<volume>62</volume>(<issue>8</issue>):<fpage>2035</fpage>&#8208;<lpage>2044</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10620-016-4432-7</pub-id><pub-id pub-id-type="pmid">28050780</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0153"><label>153</label><mixed-citation publication-type="journal" id="nmo14911-cit-0153"><string-name name-style="western"><surname>Parikh</surname><given-names>SV</given-names></string-name>, <string-name name-style="western"><surname>Segal</surname><given-names>ZV</given-names></string-name>, <string-name name-style="western"><surname>Grigoriadis</surname><given-names>S</given-names></string-name>, et&#160;al. <article-title>Canadian network for mood and anxiety treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication</article-title>. <source>J Affect Disord</source>. <year>2009</year>;<volume>117</volume>(<issue>Suppl 1</issue>):<fpage>S15</fpage>&#8208;<lpage>S25</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jad.2009.06.042</pub-id><pub-id pub-id-type="pmid">19682749</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0154"><label>154</label><mixed-citation publication-type="journal" id="nmo14911-cit-0154"><string-name name-style="western"><surname>Venkatesan</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Hillard</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Ayer</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>Acute and long&#8208;term effects of app&#8208;delivered heartfulness meditation on psychological outcomes and the endocannabinoid signaling system in cyclic vomiting syndrome</article-title>. <source>Clin Transl Gastroenterol</source>. <year>2024</year>;<volume>15</volume>(<issue>7</issue>):<elocation-id>e00711</elocation-id>. doi:<pub-id pub-id-type="doi">10.14309/ctg.0000000000000711</pub-id><pub-id pub-id-type="pmid">38713142</pub-id><pub-id pub-id-type="pmcid">PMC11272346</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0155"><label>155</label><mixed-citation publication-type="journal" id="nmo14911-cit-0155"><string-name name-style="western"><surname>Hasler</surname><given-names>WL</given-names></string-name>, <string-name name-style="western"><surname>Levinthal</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Tarbell</surname><given-names>SE</given-names></string-name>, et&#160;al. <article-title>Cyclic vomiting syndrome: pathophysiology, comorbidities, and future research directions</article-title>. <source>Neurogastroenterol Motil</source>. <year>2019</year>;<volume>31</volume>(<issue>S2</issue>):<elocation-id>e13607</elocation-id>. doi:<pub-id pub-id-type="doi">10.1111/nmo.13607</pub-id><pub-id pub-id-type="pmid">31241816</pub-id><pub-id pub-id-type="pmcid">PMC6899706</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0156"><label>156</label><mixed-citation publication-type="journal" id="nmo14911-cit-0156"><string-name name-style="western"><surname>Otto</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Riepl</surname><given-names>RL</given-names></string-name>, <string-name name-style="western"><surname>Klosterhalfen</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Enck</surname><given-names>P</given-names></string-name>. <article-title>Endocrine correlates of acute nausea and vomiting</article-title>. <source>Auton Neurosci</source>. <year>2006</year>;<volume>129</volume>(<issue>1&#8211;2</issue>):<fpage>17</fpage>&#8208;<lpage>21</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.autneu.2006.07.010</pub-id><pub-id pub-id-type="pmid">16945594</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0157"><label>157</label><mixed-citation publication-type="journal" id="nmo14911-cit-0157"><string-name name-style="western"><surname>Venkatesan</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Prieto</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Barboi</surname><given-names>A</given-names></string-name>, et&#160;al. <article-title>Autonomic nerve function in adults with cyclic vomiting syndrome: a prospective study</article-title>. <source>Neurogastroenterol Motil</source>. <year>2010</year>;<volume>22</volume>(<issue>12</issue>):<fpage>1303</fpage>&#8208;<lpage>1308</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2982.2010.01577.x</pub-id><pub-id pub-id-type="pmid">20667005</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0158"><label>158</label><mixed-citation publication-type="book" id="nmo14911-cit-0158"><string-name name-style="western"><surname>McEwen</surname><given-names>BS</given-names></string-name>. <part-title>Allostasis and allostatic load: implications for neuropsychopharmacology</part-title>. In: <person-group person-group-type="editor"><string-name name-style="western"><surname>Hyman</surname><given-names>SE</given-names></string-name></person-group>, ed. <source>The Science of Mental Health: Stress and the Brain</source>. Vol <volume>9</volume>. <publisher-name>Routledge</publisher-name>; <year>2013</year>:<fpage>2</fpage>&#8208;<lpage>18</lpage>.</mixed-citation></ref><ref id="nmo14911-bib-0159"><label>159</label><mixed-citation publication-type="journal" id="nmo14911-cit-0159"><string-name name-style="western"><surname>Kumar</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Bashar</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Reddy</surname><given-names>N</given-names></string-name>, et&#160;al. <article-title>Cyclic vomiting syndrome (CVS): is there a difference based on onset of symptoms &#8208; pediatric versus adult?</article-title><source>BMC Gastroenterol</source>. <year>2012</year>;<volume>12</volume>(<issue>1</issue>):<elocation-id>52</elocation-id>. doi:<pub-id pub-id-type="doi">10.1186/1471-230X-12-52</pub-id><pub-id pub-id-type="pmid">22639867</pub-id><pub-id pub-id-type="pmcid">PMC3443054</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0160"><label>160</label><mixed-citation publication-type="journal" id="nmo14911-cit-0160"><string-name name-style="western"><surname>Bashashati</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Bradshaw</surname><given-names>HB</given-names></string-name>, <string-name name-style="western"><surname>Johnson</surname><given-names>CT</given-names></string-name>, et&#160;al. <article-title>Plasma endocannabinoids and cannabimimetic fatty acid derivatives are altered in cyclic vomiting syndrome: the effects of sham feeding</article-title>. <source>J Invest Med</source>. <year>2023</year>;<volume>71</volume>(<issue>8</issue>):<fpage>821</fpage>&#8208;<lpage>829</lpage>. doi:<pub-id pub-id-type="doi">10.1177/10815589231196591</pub-id><pub-id pub-id-type="pmid">37572030</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0161"><label>161</label><mixed-citation publication-type="journal" id="nmo14911-cit-0161"><string-name name-style="western"><surname>Richards</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Lapoint</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Burillo&#8208;Putze</surname><given-names>G</given-names></string-name>. <article-title>Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment</article-title>. <source>Clin Toxicol</source>. <year>2018</year>;<volume>56</volume>(<issue>1</issue>):<fpage>15</fpage>&#8208;<lpage>24</lpage>. doi:<pub-id pub-id-type="doi">10.1080/15563650.2017.1349910</pub-id><pub-id pub-id-type="pmid">28730896</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0162"><label>162</label><mixed-citation publication-type="journal" id="nmo14911-cit-0162"><string-name name-style="western"><surname>Murphy</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Whelan</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Griffin</surname><given-names>LB</given-names></string-name>, <string-name name-style="western"><surname>Hamel</surname><given-names>MS</given-names></string-name>. <article-title>A pilot randomized control trial of topical capsaicin as adjunctive therapy for nausea and vomiting of pregnancy</article-title>. <source>Am J Obstet Gynecol MFM</source>. <year>2023</year>;<volume>5</volume>(<issue>7</issue>):<elocation-id>100997</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.ajogmf.2023.100997</pub-id><pub-id pub-id-type="pmid">37271593</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0163"><label>163</label><mixed-citation publication-type="journal" id="nmo14911-cit-0163"><string-name name-style="western"><surname>Mooventhan</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Nivethitha</surname><given-names>L</given-names></string-name>. <article-title>Scientific evidence&#8208;based effects of hydrotherapy on various systems of the body</article-title>. <source>N Am J Med Sci</source>. <year>2014</year>;<volume>6</volume>(<issue>5</issue>):<fpage>199</fpage>&#8208;<lpage>209</lpage>. doi:<pub-id pub-id-type="doi">10.4103/1947</pub-id><pub-id pub-id-type="pmid">24926444</pub-id><pub-id pub-id-type="pmcid">PMC4049052</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0164"><label>164</label><mixed-citation publication-type="journal" id="nmo14911-cit-0164"><string-name name-style="western"><surname>Hoppe</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Frick</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>&#197;hs</surname><given-names>F</given-names></string-name>, et&#160;al. <article-title>Association between amygdala neurokinin&#8208;1 receptor availability and anxiety&#8208;related personality traits</article-title>. <source>Transl Psychiatry</source>. <year>2018</year>;<volume>8</volume>(<issue>1</issue>):<fpage>168</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41398-018-0163-1</pub-id><pub-id pub-id-type="pmid">30154470</pub-id><pub-id pub-id-type="pmcid">PMC6113290</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0165"><label>165</label><mixed-citation publication-type="journal" id="nmo14911-cit-0165"><string-name name-style="western"><surname>Hassanzadeh</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Hassanzadeh</surname><given-names>A</given-names></string-name>. <article-title>Involvement of the neurotrophin and cannabinoid systems in the mechanisms of action of neurokinin receptor antagonists</article-title>. <source>Eur Neuropsychopharmacol</source>. <year>2011</year>;<volume>21</volume>(<issue>12</issue>):<fpage>905</fpage>&#8208;<lpage>917</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.euroneuro.2011.01.002</pub-id><pub-id pub-id-type="pmid">21316930</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0166"><label>166</label><mixed-citation publication-type="journal" id="nmo14911-cit-0166"><string-name name-style="western"><surname>Heldt</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Davis</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ratti</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Corsi</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Trist</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Ressler</surname><given-names>KJ</given-names></string-name>. <article-title>Anxiolytic&#8208;like effects of the neurokinin 1 receptor antagonist GR&#8208;205171 in the elevated plus&#8208;maze and contextual fear&#8208;potentiated startle model of anxiety in gerbils</article-title>. <source>Behav Pharmacol</source>. <year>2009</year>;<volume>20</volume>(<issue>7</issue>):<fpage>584</fpage>&#8208;<lpage>595</lpage>. doi:<pub-id pub-id-type="doi">10.1097/FBP.0b013e32832ec594</pub-id><pub-id pub-id-type="pmid">19675456</pub-id><pub-id pub-id-type="pmcid">PMC2946835</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0167"><label>167</label><mixed-citation publication-type="journal" id="nmo14911-cit-0167"><string-name name-style="western"><surname>Tillisch</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Labus</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Nam</surname><given-names>B</given-names></string-name>, et&#160;al. <article-title>Neurokinin&#8208;1&#8208;receptor antagonism decreases anxiety and emotional arousal circuit response to noxious visceral distension in women with irritable bowel syndrome: a pilot study</article-title>. <source>Aliment Pharmacol Ther</source>. <year>2012</year>;<volume>35</volume>(<issue>3</issue>):<fpage>360</fpage>&#8208;<lpage>367</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2036.2011.04958.x</pub-id><pub-id pub-id-type="pmid">22221140</pub-id><pub-id pub-id-type="pmcid">PMC4073664</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0168"><label>168</label><mixed-citation publication-type="journal" id="nmo14911-cit-0168"><string-name name-style="western"><surname>Zhang</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Lao</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Marviz&#243;n</surname><given-names>JCG</given-names></string-name>. <article-title>Cannabinoid CB1 receptor facilitation of substance P release in the rat spinal cord, measured as neurokinin 1 receptor internalization</article-title>. <source>Eur J Neurosci</source>. <year>2010</year>;<volume>31</volume>(<issue>2</issue>):<fpage>225</fpage>&#8208;<lpage>237</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1460-9568.2009.07075.x</pub-id><pub-id pub-id-type="pmid">20074214</pub-id><pub-id pub-id-type="pmcid">PMC2857979</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0169"><label>169</label><mixed-citation publication-type="journal" id="nmo14911-cit-0169"><string-name name-style="western"><surname>Witsil</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Mycyk</surname><given-names>MB</given-names></string-name>. <article-title>Haloperidol, a novel treatment for cannabinoid hyperemesis syndrome</article-title>. <source>Am J Ther</source>. <year>2017</year>;<volume>24</volume>(<issue>1</issue>):<fpage>e64</fpage>&#8208;<lpage>e67</lpage>. doi:<pub-id pub-id-type="doi">10.1097/MJT.0000000000000157</pub-id><pub-id pub-id-type="pmid">25393073</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0170"><label>170</label><mixed-citation publication-type="journal" id="nmo14911-cit-0170"><string-name name-style="western"><surname>Belkacemi</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Darmani</surname><given-names>NA</given-names></string-name>. <article-title>Dopamine receptors in emesis: molecular mechanisms and potential therapeutic function</article-title>. <source>Pharmacol Res</source>. <year>2020</year>;<volume>161</volume>:<elocation-id>105124</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.phrs.2020.105124</pub-id><pub-id pub-id-type="pmid">32814171</pub-id><pub-id pub-id-type="pmcid">PMC7755683</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0171"><label>171</label><mixed-citation publication-type="journal" id="nmo14911-cit-0171"><string-name name-style="western"><surname>Lupica</surname><given-names>CR</given-names></string-name>, <string-name name-style="western"><surname>Riegel</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Hoffman</surname><given-names>AF</given-names></string-name>. <article-title>Marijuana and cannabinoid regulation of brain reward circuits</article-title>. <source>Br J Pharmacol</source>. <year>2004</year>;<volume>143</volume>(<issue>2</issue>):<fpage>227</fpage>&#8208;<lpage>234</lpage>. doi:<pub-id pub-id-type="doi">10.1038/sj.bjp.0705931</pub-id><pub-id pub-id-type="pmid">15313883</pub-id><pub-id pub-id-type="pmcid">PMC1575338</pub-id></mixed-citation></ref><ref id="nmo14911-bib-0172"><label>172</label><mixed-citation publication-type="journal" id="nmo14911-cit-0172"><string-name name-style="western"><surname>Kibret</surname><given-names>BG</given-names></string-name>, <string-name name-style="western"><surname>Canseco&#8208;Alba</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Onaivi</surname><given-names>ES</given-names></string-name>, <string-name name-style="western"><surname>Engidawork</surname><given-names>E</given-names></string-name>. <article-title>Crosstalk between the endocannabinoid and mid&#8208;brain dopaminergic systems: implication in dopamine dysregulation</article-title>. <source>Front Behav Neurosci</source>. <year>2023</year>;<volume>17</volume>:<elocation-id>1137957</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fnbeh.2023.1137957</pub-id><pub-id pub-id-type="pmid">37009000</pub-id><pub-id pub-id-type="pmcid">PMC10061032</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>